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Abstract: (Carbo)nucleoside derivatives constitute an important 
class of pharmaceuticals, yet there are only few convergent 
methods to access new analogues. In this communication, we 
report the first synthesis of thymine, uracil and 5-fluorouracil 
substituted diester donor-acceptor cyclopropanes and their use 
in the indium- and tin-catalyzed [3+2] annulations with 
aldehydes, ketones and enol ethers. The obtained diester 
products could be easily decarboxylated and reduced to the 
corresponding alcohols. The method gives access to a broad 
range of new (carbo)nucleoside analogues in only four-five steps 
and will be highly useful for the synthesis of libraries of 
bioactive compounds. 
The natural nucleosides constitute the building blocks of DNA and 
RNA. The interaction of enzymes and other biomolecules with 
nucleosides is essential for the regulation of genetic expression and 
cell replication. Therefore, the nucleoside scaffold  constitutes a 
privileged structure in medicinal chemistry (Figure 1).[1] In addition 
to bioactive natural products, such as the antiviral and antibiotic 
aristeromycin (1), more than 45 FDA approved drugs are nucleoside 
analogues. Besides only slightly modified analogues, such as 
cytarabine (2) and telbivudine (3), more elaborated compounds 
derived from thymine have been successful, such as the 
carbonucleoside stavudine (4), the anti-HIV front drug 
azidothymidine (5) or the fluorinated floxuridine (6). Nevertheless, 
resistances are emerging in viral infections, and less toxic anti-
cancer agents would be highly desirable, asking for the development 
of new bioactive nucleoside analogues.  
The synthesis of nucleoside analogues has been the focus of 
intensive effort since several decades.[2] Nevertheless, most methods 
are based on a linear approach involving first the synthesis of a 
ribose analogue followed by introduction of the nucleobase, either 
via formation of the C-N bond using a substitution reaction from an 
acetate I (Vorbrüggen reaction)[2b] or a condensation reaction from 
an aminoglycoside II[2a]  (Scheme 1, A). This approach is efficient if 
the targeted analogue is similar to a natural ribose derivative, but 
can involve a long multi-step sequence if a more elaborate scaffold 
is desired.[3]  This is particularly true for carbonucleoside analogues, 
for which elegant synthetic approaches involving ring-closing 
metathesis,[3a] Pauson-Khand[3b]  or desymmetrization starting from 
cyclopentadiene and proceeding via diols, [3c-e]  Vince’s lactam[3f-g]  
or nitroso cycloaddition reactions[3h]  have been developed.  
 
Figure 1. Natural and synthetic bioactive nucleoside analogues. 
Our group has introduced the use of imide-substituted diester 
cyclopropanes in [3+2] annulation reactions.[4] With this new class 
of donor-acceptor cyclopropanes,[5] access to intermediates of type 
II became possible (Scheme 2, B). Nevertheless, the efficiency of 
the annulation process was mitigated by the necessary removal of 
the phthalimide group followed by DNA-base construction, which 
would add several steps to the synthetic sequence. Furthermore, the 
deprotection of the pththalimide group could not be achieved on the 
tetrahydrofurylamines. 
If a DNA-base could be used as amino substituent on the 
cyclopropane, a more efficient synthesis would become possible 
(Scheme 1, C). Herein, we would like to report the successful 
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implementation of this strategy, including: (1) the first efficient 
three-step synthesis of thymine/uracil donor-acceptor cyclopropanes, 
(2) their successful [3+2] cycloaddition with enol ethers, aldehydes 
and ketones and (3) their further derivatization to access 
hydroxylated analogues.  
Scheme 1. Traditional approach (A), our previous work (B) and new strategy 
(C) to access (carbo)nucleoside analogues. Phth = Phthalimido, Pg = protecting 
group, LA = Lewis Acid. 
In our work with phthalimide-substituted cyclopropanes, 
modulating the electronic density on the nitrogen was essential for a 
successful annulation reaction. Based on the fact that thymine and 
phthalimide have similar pKa values (8.3 and 9.9 respectively), we 
started our investigations with thymine-substituted cyclopropanes 
(Scheme 2, A). Cyclopropane 7a was easily accessed by selective 
mono benzoylation of thymine (10),[6] followed by Pd-catalyzed 
vinylation under slightly modified reported conditions[7] and 
cyclopropanation using Du Bois’ Rhodium-espino complex.[8] As 
N3-selective tert-butylbenzylation was not possible, a longer 
sequence involving temporary Boc protection of the N1 nitrogen 
was necessary in the case of cyclopropane 7b.[9] 
With aminocyclopropanes 7a and 7b in hand, we first examined 
the iron-catalyzed [3+2] annulation reaction with benzaldehyde (14) 
(Scheme 2, B).[4c] The reaction was successful for both substrates 7a 
and 7b. Nevertheless, we were never able to remove either of the 
protecting groups on the nitrogen of thymine. We decided 
consequently to turn to the easily removable tert-butoxy carbonyl 
(Boc) protecting group. 
Due to the incompatibility of the Boc group with the vinylation 
conditions, a method to access selectively N1-vinyl thymine prior to 
introduction of the Boc group was required. All the reported 
methods to access this substrate proceeded with low yield and 
reproducibility in our hands.[10] Nevertheless, we discovered that 
N1-selective Pd-catalyzed vinylation was possible in 45% yield 
from thymine itself in presence of trimethylsilyltriflate (TMSOTf) 
as additive (Scheme 3, A). Boc-protection[11] and cyclopropanation 
then proceeded in good yields, giving access to 7c in only three 
steps. 
 
Scheme 2. Synthesis of aminocyclopropanes 7a and 7b (A) and first attempts 
of [3+2] annulation (B). Reaction conditions: a) BzCl, pyridine, CH3CN, 69%. b) 
4 mol% Na2PdCl4, vinylacetate, 80 °C, 65%. c) 0.2 mol% Rh2(esp)2, 
diazodimethylmalonate, CH2Cl2. d) Boc2O, DMAP, CH3CN. e) tBuBnBr, NaH, 
DMF, 0 °C, quant. f) K2CO3, MeOH, 81%. g) 4 mol% Na2PdCl4, vinylacetate, 
80 °C, 23%, h) 5 mol% Fe2O3•Al2O3, CH2Cl2. 
 
Scheme 3. Synthesis of aminocyclopropanes 7c (A) and optimized conditions 
for [3+2] annulation reactions (B). Reaction conditions: a) 4 mol% Pd(OAc)2, 
vinylacetate, TMSOTf, 70 °C, DMF, 45%. b) Boc2O, DMAP, CH2Cl2, 75%. c) 
0.02 mol% Rh2(esp)2, diazodimethylmalonate, CH2Cl2. d) 20 mol% In(OTf)3, 
CH2Cl2; then EtOH, 70 °C. e) 10 mol% SnCl4, CH2Cl2, -20 °C; then EtOH, 70 °C. 
First attempts towards the annulation of 7c with benzaldehyde 
(14) using an iron catalyst gave the desired product only in low yield 
(<27%). This was due to loss of the Boc protecting group during 
both reaction and purification. Changing to In(OTf)3 as catalyst
[12] 
and direct Boc deprotection of the crude product by heating in 
ethanol at 70 °C afforded the desired NH-free product 8c in 87% 
yield (Scheme 3, B). Aminocyclopropane 7c could also be used in 
other [3+2] annulation processes involving either ketones[4b] or silyl 
enol ethers[4a] to give tetrahydrofuryl amine 8d and cyclopentyl 
amine 9a in 94% and 84% yield respectively. In this case, the lower 
reactivity of 7c compared with phthalimide-substituted 
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cyclopropanes required the use of a higher temperature (-20 instead 
of -78 °C) in the tin-catalyzed process. 
We then turned to the investigation of the scope of the [3+2] 
annulation (Figure 2).[13] The reaction was successful in the case of 
aromatic (products 8c and 8e), aliphatic (products 8f) and vinylic 
aldehydes product 8g). Excellent diastereoselectivity (> 20:1) was 
observed, except for product 8g (5:1). The same was also true for 
ketones (products 8d and 8h-k), although the diastereoselectivity 
was lower for vinylic ketones (product 8k). With enol ethers, more 
substituted derivatives, such as tetrasubstituted cyclopentane 9c, 
could also be accessed. The [3+2] annulation product was obtained 
in 55% yield with a dienol ether as partner (product 9d). Finally, 
modification of the thymine substituent was also examined. Both 
cyclopropanes derived from uracil and 5-fluoro-uracil could also be 
used in the annulation reaction with aldehydes, ketones and enol 
ethers (products 18-21).[14] 
For most nucleoside drugs enzymatic phosphorylation of a 
hydroxy group is an important step in the mode of action.[1] 
Modification of the obtained products to include hydroxy group(s) 
would be consequently highly rewarding in the quest of new 
bioactive compounds. To reach this goal, saponification followed by 
decarboxylation of diester 8c gave access to a single isomer of the 
corresponding carboxylic acid,[15] which could be reduced to 
primary alcohol 22 in 71% overall yield (Scheme 4, A). The same 
sequence was also successful for styrene derivative 8g, giving the 
corresponding alcohol 24 in 59% yield. Products 8d and 8h could 
also be converted into the desired alcohols 23 and 25 in 62 and 64% 
yield respectively. In the case of the carbonucleoside analogues, 
dibenzylester cyclopentylamine 26 could be converted into the 
corresponding diacid by hydrogenation.[16] Heating the neat crude 
diacid to 80 °C led then to decarboxylation and silyl ether 
elimination to give acid 27 (Scheme 4, B). Pd-catalyzed 
hydrogenation followed by acid reduction gave the corresponding 
unstable saturated alcohol, which was isolated as silyl ether 28.  
 
Scheme 4. Modification of the tetrahydrofuran (A) and cyclopentane (B) 
products. Reaction conditions: a) KOH, MeOH. b) BH3•SMe2, THF. c) 10% Pd/C, 
1 atm H2, EtOH, 57 °C, then neat, 80°C. d) 5% Pd/C, 1 atm H2, EtOH, 85%. e) 
I
Pr3SiCl, DMF, imidazole, 55% over two steps. 
Figure 2. Scope of the [3+2] annulation reaction. The reactions were run on 0.40 mmol scale using the conditions of Scheme 3 and isolated yields after column 
chromatography are given. See Supporting Information for full experimental details. Thy = Thymine, Ur = Uracil, 5F-Ur = 5-Fluro-Uracil. 
 
In conclusion, we have reported the first synthesis of 
nucleobase-substituted diester cyclopropanes and their use in 
cycloaddition with aldehydes, ketones and enol ethers. This new 
transformation gave access in a few steps to important nucleoside 
analogues, which were easily modified to give hydroxylated 
derivatives. Future work will focus on the synthesis of a broader 
range of analogues to build up a chemical library for biological 
testing and extending the scope of the reaction to the purine class of 
nucleobases. 
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1. General methods. 
 
All reactions were carried out in flamed-dried glassware under an atmosphere of nitrogen, 
unless stated otherwise. HPLC grade solvents purchased from Sigma-Aldrich or freshly 
distilled solvents were used for flash chromatography. Reaction solvents were dried by 
passage over activated alumina under nitrogen atmosphere (H2O content < 30 ppm, Karl-
Fischer titration). Commercially available reagents were purchased from Acros, Aldrich, 
Fluka, VWR, Aplichem, Merck or TCI and used without any further purification. 
Chromatographic purification was performed as flash chromatography using Macherey-Nagel 
silica 40-63, 60 Å, using the solvents indicated as eluent with 0.1-0.5 bar pressure. TLC was 
performed on Merck silica gel 60 F254 TLC plates and visualized with UV light and 
permanganate stain. Melting points were measured on a calibrated Büchi B-540 melting 
point apparatus using open glass capillaries. 1H NMR spectra were measured on a Brucker 
DPX-400, 400 MHz spectrometer, all signals are reported in ppm with the corresponding 
internal solvent peak or TMS as standard. The data is being reported as (s = singlet, d = 
doublet, t = triplet, q = quadruplet, qi = quintet, m = multiplet or unresolved, br = broad signal, 
coupling constant(s) in Hz, integration; interpretation). 13C NMR spectra were carried out with 
1H-decoupling on a Brucker DPX-400 100 MHz. All signals are reported in ppm with the 
corresponding internal solvent signal or TMS as standard. Infrared spectra were obtained on 
a JASCO FT-IR B4100 spectrophotometer with an ATR PRO410-S and a ZnSe prisma and 
are reported as cm-1 (w = weak, m = medium, s = strong, sh = shoulder). High resolution 
mass spectrometric measurements were performed by the mass spectrometry service of 
ISIC at the EPFL on a MICROMASS (ESI) Q-TOF Ultima API.  
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2. Starting materials. 
2.1 Diazomalonates. 
Dibenzyl 2-diazomalonate (30). 
 
In flame dried flask under nitrogen, 4-acetamidobenzenesulfonyl azide (1.27 g, 5.28 mmol, 
1.5 eq) was dissolved in acetonitrile (15 mL) and triethylamine (1.17 mL, 8.44 mmol, 2.4 eq) 
and dibenzyl malonate (29) (0.88 ml, 3.5 mmol, 1eq) were added. The reaction mixture was 
stirred at room temperature for 2 days. The solvent was evaporated and the crude product 
was filtered on coton with acetonitrile (30 mL). The crude mixture was concentrated under 
reduced pressure and filtered on coton one more time with DCM (30 mL) and finally purified 
by column chromatography, eluting with pentane/AcOEt (9:1) and 1% NEt3 mixture to obtain 
the pure diazo-compound 30 (1.02 g, 3.29 mmol, 93%) as a slightly yellow solid. 
 
RF (AcOEt/Pent (1:9) = 0.22. 
 
Mp 54.8-55.4°C. (Decomposition)  
 
1H NMR (400 MHz, Chloroform-d) δ 7.39- 7.34 (m, 10H, Ar-H), 5.28 (s, 4H, CH2). 
 
13C NMR (101 MHz, Chloroform-d) δ 160.8, 135.3, 128.7, 128.5, 128.3, 67.1. 
One carbon is not resolved. 
 
IR 3035 (w), 2141 (s), 1757 (s), 1689 (m), 1388 (s), 1271 (m), 1077 (s), 760 (s). 
 
HRMS (ESI) calcd for C17H14N2NaO4+ [M+Na]+ 333.0846; found 333.0856. 
 
Dimethyl 2-diazomalonate (32). 
 
In flame dried flask under nitrogen, 4-acetamidobenzenesulfonyl azide (6.82 g, 28.4 mmol, 
1.5 eq) was dissolved in acetonitrile (80 mL) and triethylamine (6.3 mL, 45 mmol, 2.4 eq) and 
dimethyl malonate (31) (2.2 mL, 19 mmol, 1eq) were added. The reaction mixture was stirred 
at room temperature for 1 day. The solvent was evaporated and the crude product was 
filtered on coton with acetonitrile (30 mL). The crude mixture was concentrated under 
reduced pressure and filtered on coton one more time with DCM (30 mL) and finally purified 
by column chromatography, eluting with pentane/AcOEt (9:1) and 1% NEt3 mixture to obtain 
the pure diazo-compound 32 (2.67 g, 16.9 mmol, 94%) as a slightly yellow oil (solid at 4 °C). 
 
1H NMR (400 MHz, Chloroform-d) δ 3.84 (s, 4H, CH2). 
 
1H NMR values correspond to the li1terature.[1] 
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2.2 Thymine cyclopropanes. 
3-Benzoyl-5-methylpyrimidine-2,4(1H,3H)-dione (33). 
 
Following the procedure of Zhou and co-workers.[2], benzoyl chloride (1.01 mL, 8.72 mmol, 
2.2 eq) and thymine (10) (0.050 g, 4.0 mmol, 1.0 eq) were suspended in a mixture of 
acetonitrile (4 mL) and pyridine (1.6 mL, 4.0 mmol, 1.0 eq) in a flame-dried flask under 
nitrogen. The reaction was stirred under nitrogen atmosphere at room temperature for 12 h. 
Then, the reaction was partitioned between DCM and water. The aqueous layer was 
extracted three times with DCM and the combined organic layers were dried over anhydrous 
K2CO3. The solvent was removed under reduced pressure. The residue was dissolved in 
dioxane (8 mL) and K2CO3 (0.3 g) in 4 mL water was added and the reaction mixture was 
stirred for 1h30. AcOH was added to reach pH 5. The crude residue was concentrated under 
vacuo and suspended in 20 mL of a saturated solution of NaHCO3 for 1 h and filtered with 
cold water. The pure product 33 (0.63 g, 2.7 mmol, 69% yield) was obtained after 
recrystallization in acetone (10 mL) as colorless needles. 
 
1H NMR (400 MHz, DMSO) δ 11.37 (s, 1H, N-H), 7.94 (m, 2H, Ar-H), 7.79 (m, 1H, Ar-H), 
7.61 (m, 2H, Ar-H), 7.54 (d, J = 1.2 Hz, 1H, C=C-H), 1.83 (d, J = 1.1 Hz, 3H, CH3). 
NMR values correspond to the literature.[2] 
 
3-Benzoyl-5-methyl-1-vinylpyrimidine-2,4(1H2,3H)-dione (11). 
 
Following an adapted procedure of Baret and co-workers.[3], 3-benzoyl-5-methylpyrimidine-
2,4(1H,3H)-dione (33) (0.061 g, 0.27 mmol, 1.0 eq) and Na2PdCl4 (8 mg, 0.03 mmol, 10 
mol%) were heated in vinyl acetate (5 mL) at 80 °C for 6 h in a flamed dried flask under 
nitrogen. The reaction mixture was allowed to cool down and was filtered on a syringe filter. 
Then, the crude residue was concentrated under reduced pressure and purified by column 
chromatography using a mixture of DCM/AcOEt (9.5:0.5) as eluting solvent. The pure 
product 11 (0.40 g, 0.16 mmol, 65% yield) was obtained as a white solid. 
 
RF (DCM/AcOEt (9.5:0.5)) = 0.73. 
 
1H NMR (400 MHz, Chloroform-d) δ 8.02 – 7.93 (m, 2H, Ar-H), 7.68 (ddt, J = 8.7, 7.1, 1.3 Hz, 
1H, Ar-H), 7.59 – 7.43 (m, 3H, Ar-H and C=CH), 7.21 (dd, J = 16.0, 9.1 Hz, 1H, vinyl-C-H), 
5.17 (dd, J = 16.0, 2.3 Hz, 1H, vinyl-CH2), 5.00 (dd, J = 9.1, 2.3 Hz, 1H, vinyl-CH2), 2.05 (d, J 
= 1.3 Hz, 3H, CH3).  
 
13C NMR (101 MHz, Chloroform-d) δ 168.4, 162.5, 148.3, 135.1, 134.3, 131.4, 130.5, 129.5, 
129.2, 112.1, 101.2, 12.7. 
 
IR 3125 (w), 1753 (m), 1701 (s), 1656 (s), 1439 (m), 1345 (m), 1233 (m). 
 
HRMS (ESI) calcd for C14H13N2O3+ [M+H]+ 257.0921; found 257.0913. 
                                                 
[2] J. Zhou, P. B. Shevlin, Synth. Commun., 1997, 27, 3591–3597. 
[3] N. Baret, J.-P. Dulcere, J. Rodriguez, J.-M. Pons, R. Faure, Eu. J. Org. Chem., 2000, 2000, 1507–1516. 
4 
 
NMR values correspond to the literature[3] 
 
Dimethyl 2-(3-benzoyl-5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)cyclopropane-
1,1-dicarboxylate (7a). 
 
Dimethyl 2-diazomalonate (0.078 g, 0.40 mmol, 1.5 eq) was added to a solution of 3-
benzoyl-1-vinylpyrimidine-2,4(1H,3H)-dione (11) (0.064 g, 0.26 mmol, 1.0 eq) and Rh2(esp)2 
(0.4 mg, 0.5 µmol, 5% mol). The reaction mixture was stirred in anhydrous DCM (1 mL) at 
room temperature for 4 h in a flamed dried flask under nitrogen. Then, the crude residue was 
concentrated under reduced pressure and purified by column chromatography using a 
mixture of AcOEt/PET (7:3, 1% NEt3) affording the pure product 7a (0.083 g, 0.20 mmol, 
79% yield) as a colorless foam. 
 
RF (AcOEt/PET (7:3, 1% NEt3)) = 0.23. 
 
Mp 61.2-63.0°C. 
 
1H NMR (400 MHz, Chloroform-d) δ 7.98 – 7.88 (m, 2H, Ar-H), 7.70 – 7.60 (m, 1H, Ar-H), 
7.54 – 7.45 (m, 2H, Ar-H), 7.11 (q, J = 1.2 Hz, 1H, thymine C=CH), 4.00 (dd, J = 8.1, 6.4 Hz, 
1H, cyclopropane-CH), 3.79 (s, 3H, ester-CH3), 3.68 (s, 3H, ester-CH3), 2.26 (t, J = 6.4 Hz, 
1H, cyclopropane-CH2), 2.05 – 1.95 (m, 4H, cyclopropane-CH2 and thymine-CH3). 
 
13C NMR (101 MHz, Chloroform-d) δ 168.3, 167.4, 166.7, 162.7, 150.1, 138.8, 135.0, 131.5, 
130.6, 129.0, 111.0, 53.2, 53.2, 42.7, 34.8, 20.3, 12.5. 
 
IR 3125 (w), 3067 (w), 1747 (s), 1656 (s), 1436 (m), 1283 (m), 1233 (m). 
 
HRMS (ESI) calcd for C19H19N2O7+ [M+H]+ 387.1192; found 387.1194. 
 
Tert-butyl 5-methyl-2,4-dioxo-3,4-dihydropyrimidine-1(2H)-carboxylate (12). 
4 
Following the procedure described by Jaime-Figueroa and co-workers.[4], thymine (10) (1.0 g, 
7.9 mmol, 1.0 eq), di-tert-butyl dicarbonate (1.7 g, 7.9 mmol, 1.0 eq) and DMAP (0.1 g, 0.8 
mmol, 0.1 eq) were stirred in a flame-dried flask under nitrogen with acetonitrile (40 mL) for 4 
h at room temperature. Then, the crude residue was concentrated under reduced pressure 
and purified by column chromatography using a mixture of DCM/AcOEt (9:1) as eluting 
solvent. The pure product 12 (1.6 g, 7.0 mmol, 88% yield) was obtained as a white solid. 
 
RF (DCM/AcOEt (9:1)) = 0.18. 
 
1H NMR (400 MHz, DMSO-d6) δ 11.41 (br. s, 1H, N-H), 7.72 (s, 1H, C=C-H), 1.81 (s 3H, 
CH3), 1.46 (s, 9H, BOC). 
 
                                                 
[4] S. Jaime-Figueroa, A. Zamilpa, A. Guzmán, D. J. Morgans, Synth. Commun., 2001, 31, 3739–3746. 
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IR 3306 (w), 1743 (s), 1706 (s), 1359 (w), 1306 (m), 1152 (m). 
 
HRMS (ESI) calcd for C10H15N2O4+ [M+H]+ 227.1026; found 227.1030. 
NMR values correspond to the literature.[4] 
 
Tert-butyl 3-(4-(tert-butyl)benzyl)-5-methyl-2,4-dioxo-3,4-dihydropyrimidine-1(2H)-
carboxylate (34). 
 
Following a procedure described by Jacobsen and co-workers.[5], tert-butyl 5-methyl-2,4-
dioxo-3,4-dihydropyrimidine-1(2H)-carboxylate (12) (0.75 g, 3.3 mmol, 1.0 eq) and NaH 
(0.159 g, 3.98 mmol, 1.2 eq) were stirred 30 min at room temperature in DMF (20 mL) in a 
flame-dried flask under nitrogen. Then 1-(bromomethyl)-4-(tert-butyl)benzene (0.731 mL, 
3.98 mmol, 1.2 eq). was added at 0 °C. The reaction mixture was stirred at room temperature 
for 45 min and was partitioned between AcOEt and water. The aqueous layer was extracted 
three times with AcOEt and the organic layers were washed once with a sat. NH4Cl solution 
and dried over anhydrous K2CO3. The solvent was removed under reduced pressure. The 
pure product 34 (1.24 g, 3.32 mmol, quantitative yield) was obtained after column 
chromatography using DCM as eluting solvent as white powder. 
 
RF (DCM) = 0.24. 
 
Mp 145.6-146.7°C. 
 
1H NMR (400 MHz, Chloroform-d) δ 7.62 (q, J = 1.3 Hz, 1H, thymine C=C-H), 7.47 – 7.39 (m, 
2H, Ar-H), 7.36 – 7.27 (m, 2H, Ar-H), 5.09 (s, 2H, benzylic-CH2), 1.96 (d, J = 1.4 Hz, 3H, 
thymine methyl), 1.60 (s, 9H, Boc), 1.29 (s, 9H, tBu). 
 
13C NMR (101 MHz, Chloroform-d) δ 163.0, 150.6, 148.8, 148.3, 133.5, 133.4, 129.1, 125.3, 
111.4, 86.6, 44.3, 34.5, 31.3, 27.8, 13.3. 
 
IR 2965 (w), 2907 (w), 1750 (s), 1681 (s), 1434 (m), 1282 (s), 1146 (s), 846 (m). 
 
HRMS (ESI) calcd for C21H29N2O4+ [M+H]+ 373.2122; found 373.2135. 
 
3-(4-(Tert-butyl)benzyl)-5-methylpyrimidine-2,4(1H,3H)-dione (35). 
 
Following a procedure described by Jacobsen and co-workers.[5], 3-(4-(tert-butyl)benzyl)-5-
methylpyrimidine-2,4(1H,3H)-dione (34) (1.4 g, 3.8 mmol, 1.0 eq), K2CO3 (0.26 g, 3.8 mmol, 
1.0 eq) were stirred in MeOH (40 mL) at room temperature for 4 h. Afterwards, the reaction 
mixture was partitioned between DCM and water. The aqueous layer was extracted three 
times with DCM and the organic layers were washed once with a sat. NH4Cl solution and 
dried over anhydrous K2CO3. The solvent was removed under reduced pressure affording 
pure 35 (0.83 g, 3.1 mmol, 81% yield) as a white solid.  
                                                 
[5] M. F. Jacobsen, M. M. Knudsen, K. V. Gothelf, J. Org. Chem., 2006, 71, 9183–9190. 
6 
 
 
Mp 198.2-200.0°C. 
 
1H NMR (400 MHz, DMSO-d6) δ 7.34 (s, 1H, thymine vinyl-C-H), 7.30 (d, J = 8.2 Hz, 2H, Ar-
H), 7.21 (d, J = 8.2 Hz, 2H, Ar-H), 4.93 (s, 2H, benzylic-CH2), 1.79 (s, 3H, thymine-CH3), 1.23 
(s, 9H, tBu). 
  
1H NMR (400 MHz, Chloroform-d) δ 9.94 – 9.87 (m, 1H, thymine N-H), 7.48 – 7.38 (m, 2H, 
Ar-H), 7.38 – 7.31 (m, 2H, Ar-H), 7.02 (dt, J = 5.3, 1.2 Hz, 1H, thymine vinyl-C-H), 5.11 (s, 
2H, benzylic-CH2), 1.95 (d, J = 1.2 Hz, 3H, thymine-CH3), 1.31 (s, 9H, 
tBu). 
 
13C NMR (101 MHz, Chloroform-d) δ 164.0, 153.2, 150.5, 134.4, 133.7, 128.7, 125.3, 110.3, 
43.6, 34.5, 31.4, 13.0. 
 
IR 3235 (w), 2963 (w), 2869 (w), 1713 (m), 1643 (s), 1515 (w), 1443 (w), 1206 (w). 
 
HRMS (ESI) calcd for C16H21N2O2+ [M+H]+ 273.1598; found 273.1599. 
1H NMR values are in accordance with the spectra performed in DMSO in the literature[5] 
 
3-(4-(Tert-butyl)benzyl)-5-methyl-1-vinylpyrimidine-2,4(1H,3H)-dione (13). 
 
Following an adapted procedure described by Baret and co-workers.[3] 3-(4-(tert-
butyl)benzyl)-5-methylpyrimidine-2,4(1H,3H)-dione (35) (0.825 g, 3.03 mmol, 1 eq) and 
Na2PdCl4 (37 mg, 0.13 mmol, 0.05 eq) were heated at 80°C in vinylacetate (10 mL) for 6 h in 
a flame-dried flask under nitrogen. The reaction mixture was cooled down and filtered on a 
syringe filter. The pure product 13 (0.21 g, 0.70 mmol, 23% yield) was obtained after column 
chromatography using a mixture of DCM/AcOEt (9.5/0.5) as a white solid. 
 
RF (DCM/AcOEt (9.5/0.5)) = 0.73. 
 
Mp 107.6-108.9°C. 
 
1H NMR (400 MHz, Chloroform-d) δ 7.50 – 7.42 (m, 2H, Ar-H ), 7.39 – 7.22 (m, 4H, Ar-H, 
thymine-H and vinyl-CH), 5.14 (s, 2H, benzyl-CH2), 5.05 (dd, J = 16.1, 2.1 Hz, 1H, thymine 
vinyl-CH2), 4.90 (dd, J = 9.1, 2.2 Hz, 1H, thymine vinyl-CH2), 2.02 (d, J = 1.3 Hz, 3H, 
thymine-CH3), 1.31 (s, 9H, 
tBu). 
 
13C NMR (101 MHz, Chloroform-d) δ 163.2, 150.6, 150.0, 133.6, 132.7, 130.6, 129.0, 125.3, 
111.4, 100.3, 44.3, 34.5, 31.3, 13.3. 
 
IR 3097 (w), 2963 (w), 2907 (w), 1709 (s), 1676 (s), 1644 (s), 1444 (m), 1377 (m), 1351 (m), 
1274 (m). 
 
HRMS (ESI) calcd for C18H23N2O2+ [M+H]+ 299.1754; found 299.1747. 
 
Dimethyl 2-(3-(4-(tert-butyl)benzyl)-5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-
yl)cyclopropane-1,1-dicarboxylate (7b). 
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3-(4-(Tert-butyl)benzyl)-5-methyl-1-vinylpyrimidine-2,4(1H,3H)-dione 13 (0.10 g, 0.34 mmol, 
1.0 eq), Rh2(esp)2 (0.51 mg, 0.67 µmol, 0.2 mol%) and dimethyl 2-diazomalonate (0.10 g, 
0.50 mmol, 1.5 eq) were stirred in a flame-dried flask under nitrogen with anhydrous DCM (4 
mL) at room temperature for 5 h. Then, the crude residue was concentrated under reduced 
pressure and purified by column chromatography with DCM and 1% NEt3, affording the pure 
product 7b (0.14 g, 0.34 mmol, quantitative yield) as a slightly yellow oil. 
 
RF (DCM) = 0.31. 
 
1H NMR (400 MHz, Chloroform-d) δ 7.41 – 7.21 (m, 4H, Ar-H), 6.93 (app. d, J = 1.4 Hz, 1H, 
thymine C=CH), 5.08 (d, J = 13.7 Hz, 1H, benzylic-CH2), 5.01 – 4.91 (m, 1H, benzylic-CH2), 
4.00 (dd, J = 8.2, 6.5 Hz, 1H, cyclopropane-CH), 3.75 (s, 3H, ester-CH3), 3.36 (s, 3H, ester-
CH3), 2.19 (t, J = 6.5 Hz, 1H, cyclopropane-CH2), 1.93 – 1.89 (m, 1H, cyclopropane-CH2), 
1.92 (s, 3H, thymine-CH3), 1.22 (s, 9H, 
tBu). 
 
13C NMR (101 MHz, Chloroform-d) δ 167.7, 166.3, 163.3, 151.7, 150.3, 137.0, 133.8, 128.7, 
125.2, 110.0, 53.1, 52.9, 44.1, 43.6, 35.0, 34.4, 31.3, 20.0, 13.2. 
 
IR 4436 (w), 3625 (w), 2958 (m), 2860 (w), 1732 (s), 1668 (s), 1448 (m), 1441 (s), 1337 (s), 
1294 (s), 1219 (s), 1131 (m). 
 
HRMS (ESI) calcd for C23H29N2O6+ [M+H]+ 429.2020; found 429.2022. 
 
1-Vinylthymine (36). 
 
Palladium acetate (0.11 g, 0.48 mmol, 0.04 eq), vinyl acetate (8.8 mL, 9.5 mmol, 2.4 eq), 
thymine (10) (1.5 g, 12 mmol, 1.0 eq) and TMSOTf (5.2 mL, 12 mmol, 2.4 eq) were stirred in 
DMF (30.0 mL) for 16 hours at 70 °C in a flame-dried sealed flask under nitrogen 
atmosphere.  Then the reaction mixture was cooled down to room temperature and 
partitioned between water (25 mL) and AcOEt (30 mL). The aqueous layer was extracted 
three times with ethyl acetate (30 mL), the organic layers were combined and washed three 
times with water (30 mL). The organic layer was dried over anhydrous magnesium sulfate 
and concentrated under reduced pressure. The crude product was purified by column 
chromatography, eluting with hex/AcOEt/NEt3 (7:3:0.01) to obtain the pure 1-vinylthymine 36 
(0.81 g, 5.3 mmol, 45% yield) as a white solid. 
 
RF (Hex/AcOEt (1:1)) = 0.5.  
 
Mp 208.0-209.1°C.  
 
1H NMR (400 MHz, Chloroform-d) δ 9.17 (s, 1 H, NH), 7.34 (s, 1 H, thymine C=C-H), 7.21 
(dd, 1 H, J =16.0, 9.1 Hz, -vinyl-CH), 5.07 (dd, 1 H, J = 16.0, 2.1 Hz, vinyl-CH2), 4.91 (dd, 1 
H, J = 9.1, 2.1 Hz, vinyl-CH2), 1.99 (s, 3 H, thymine-CH3).  
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13C NMR (101 MHz, Chloroform-d) δ 163.6, 149.3, 134.5, 129.6, 112.1, 100.5, 12.6. 
 
IR 3173 (w), 3048 (w), 1698 (s), 1644 (s), 1459 (w), 1381 (w), 1344 (m), 1278 (m), 1129 (w).  
 
HRMS (ESI) calcd for C7H9N2O2+ [M+H]+ 153.0659; found 153.0653. 
 
Tert-butyl 5-methyl-2,6-dioxo-3-vinyl-2,3-dihydropyrimidine-1(6H)-carboxylate (15). 
 
1-Vinylthymine 36 (0.92 g, 6.1 mmol, 1.0 eq), di-tert-butyl dicarbonate (2.64 g, 12.1 mmol, 
2.0 eq) and dimethylaminopyridine (1.48 g, 12.1 mmol, 2.0 eq) were stirred in acetonitrile 
(25.0 mL) for 12 h in a flame-dried flask under nitrogen. Silica and triethylamine (0.5 mL) 
were added to the reaction and the solvent was removed under reduced pressure. The dry 
residue was purified by column chromatography using a mixture of hexane/ethyl acetate/1% 
NEt3 (95:5 to 80:20) as eluting solvent. The pure product 15 (1.15 g, 4.56 mmol, 75% yield) 
was obtained as a white solid. 
 
RF (Hex/AcOEt (9:1)) = 0.2. 
 
Mp 109.9-111.2 °C.  
 
1H NMR (400 MHz, Chloroform-d) δ 7.31 (m, 1H, thymine C=C-H), 7.15 (dd, J = 16.0, 9.1 Hz, 
1H, -vinyl-CH), 5.09 (dd, J = 16.0, 2.2 Hz , 1H, vinyl-CH2), 4.94 (dd, J = 9.1, 2.2 Hz , 1H, 
vinyl-CH2), 1.99 (s, 3 H, thymine-CH3), 1.60 (s, 9 H, Boc).  
 
13C NMR (400 MHz, Chloroform-d) δ 161.0, 147.6, 147.5, 134.0, 129.6, 111.8, 101.3, 87.1, 
27.5, 12.7. 
IR 2982 (w), 2937 (w), 1778 (s), 1721 (s), 1672 (s). 
 
HRMS (ESI) calcd for C12H16N2NaO4+ [M+Na]+ 275.1002; found 275.1008. 
 
Dimethyl 2-(3-(tert-butoxycarbonyl)-5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-
yl)cyclopropane-1,1-dicarboxylate (7c). 
 
Diazomalonate 32 (1.80 g, 10.5 mmol, 1.2 eq), Rh2(esp)2 (0.013 g, 0.017 mmol, 0.02 mol%) 
and tert-butyl 5-methyl-2,6-dioxo-3-vinyl-2,3-dihydropyrimidine-1(6H)-carboxylate (15) (2.2 g, 
8.7 mmol, 1.0 eq) were stirred at room temperature in DCM (18 mL) in a flame-dried flask 
under nitrogen. After 40 min. NEt3 (0.4 mL) and silica were added and the solvent was 
removed under reduced pressure. The dried residue was purified by column chromatography 
using a mixture of pentane/ethyl acetate/1% NEt3 (1:1) as solvent gradient. The pure product 
7c (3.30 g, 8.63 mmol, 99% yield) was obtained as a slightly yellow foamy oil. 
 
RF (hexane/AcOEt/1% NEt3 (1:1)) = 0.26. 
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1H NMR (400 MHz, Chloroform-d) δ 6.94 (m, 1H, thymine C=CH), 4.01 (dd, J = 8.3, 6.4 Hz, 
1H, cyclopropane-CH), 3.79 (s, 3H, ester-CH3), 3.71 (s, 3H, ester-CH3), 2.27 (t, J = 6.5 Hz, 
1H, cyclopropane-CH2), 1.91 (m, 4H, thymine-CH3 and cyclopropane-CH2), 1.58 (s, 9H, Boc). 
 
13C NMR (101 MHz Chloroform-d) δ 167.6, 166.2, 161.2, 149.1, 147.4, 138.2, 110.5, 86.8, 
53.3, 53.2, 42.9, 35.0, 27.5, 20.0, 12.5. 
 
IR 3431 (w), 3364 (w), 2943 (m), 2866 (m), 2092 (w), 1705 (s), 1628 (m), 1505 (m), 1364 
(m), 1167 (s). 
 
HRMS (ESI) calcd for C17H22N2NaO8+ [M+Na]+ 405.1268; found 405.1271. 
 
Dibenzyl 2-(3-(tert-butoxycarbonyl)-5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-
yl)cyclopropane-1,1-dicarboxylate (37). 
 
Tert-butyl 5-methyl-2,6-dioxo-3-vinyl-2,3-dihydropyrimidine-1(6H)-carboxylate (15) (0.30 g, 
1.2 mmol, 1.0 eq) and Rh2(esp)2 (1.8 mg, 2.4 µmol, 0.02 mol%) were stirred in a flame-dried 
flask under nitrogen atmosphere with anhydrous DCM (2.3 mL) and diazomalonate 30 (0.45 
g, 1.4 mmol, 1.2 eq) was added at 0 °C. Then, the reaction mixture was allowed to warm up 
to room temperature and stirred for 14 h. Silica and triethylamine (0.5 mL) were added and 
the solvent was removed under reduced pressure. The dried residue was purified by column 
chromatography using a mixture of pentane/ethyl acetate/1% NEt3 (9:1) as eluting solvent to 
afford dibenzyl 2-(3-(tert-butoxycarbonyl)-5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-
yl)cyclopropane-1,1-dicarboxylate (37) (0.60 g, 1.1 mmol, 93% yield) as a slightly yellow 
foam. 
 
MP 76.9-82.1 °C. 
 
RF (pent/AcOEt (7:3)) = 0.29. 
 
1H NMR (400 MHz, Chloroform-d) δ 7.35 – 7.22 (m, 10 H, Ar-H), 6.83 (q, J = 1.1 Hz, 1H, 
thymine vinyl-CH), 5.27 – 5.10 (m, 4H, benzylic-CH2), 4.05 (dd, J = 8.3, 6.5 Hz, 1H, 
cyclopropane-NCH), 2.31 (t, J = 6.6 Hz, 1H, cyclopropane -CH2), 1.93 (dd, J = 8.3, 6.6 Hz, 
1H, cyclopropane -CH2), 1.78 (d, J = 1.3 Hz, 3H, thymine methyl), 1.59 (s, 9H, Boc). 
 
13C NMR (101 MHz, Chloroform-d) δ 167.2, 165.4, 161.1, 149.2, 147.5, 138.0, 135.0, 134.8, 
128.6, 128.6, 128.5, 128.4, 128.2, 110.5, 86.8, 68.3, 68.0, 43.1, 35.3, 27.5, 20.3, 12.4. 
One carbone not resolved. 
 
IR 3066 (w), 2984 (w), 2932 (w), 1783 (s), 1725 (s), 1670 (s), 1433 (m), 1373 (m), 1316 (s), 
1146 (s). 
 
HRMS (ESI) calcd for C29H30N2NaO8+ [M+Na]+ 557.1894; found 557.1885. 
 
 
 
 
 
10 
 
2.3 Uracil cyclopropane. 
1-Vinylpyrimidine-2,4(1H,3H)-dione (39). 
 
Palladium acetate (0.036 g, 0.040 mmol, 0.04 eq), vinyl acetate (0.87 mL, 10 mmol, 2.4 eq), 
uracil (38) (0.45 g, 4.0 mmol, 1.0 eq), TMSOTf (1.7 mL, 9.5 mmol, 2.4 eq) and triethylamine 
(1.4 mL, 9.5 mmol, 2.4 eq) were stirred in DMF (11.5 mL) for 16 hours at 70 °C in a flame-
dried sealed flask under nitrogen atmosphere. Then the reaction mixture was cooled down to 
room temperature and filtered on celite with AcOEt (50 mL). The crude mixture was 
concentrated under reduced pressure and purified by column chromatography, eluting with 
pentane and AcOEt mixture (2:8) to obtain the pure product 39 (0.38 g, 2.7 mmol, 69% yield) 
as a white solid. 
 
RF (AcOEt/pentane (1:1)) = 0.20. 
 
MP 175.2-176.7°C. 
 
1H NMR (400 MHz, Acetone) δ 9.21 (s, 1H, uracil N-H), 7.53 (d, J = 8.1 Hz, 1H, uracil CH), 
7.23 (dd, J = 16.0, 9.0 Hz, 1H, vinyl-CH), 5.86 (dd, J = 8.1, 1.3 Hz, 1H, uracil CH), 5.13 (dd, J 
= 16.0, 2.3 Hz, 1H, vinyl-CH2), 5.00 (dd, J = 9.0, 2.3 Hz, 1H, vinyl-CH2). 
 
13C NMR (101 MHz, Acetone) δ 162.5, 149.3, 139.1, 129.7, 102.8, 99.7. 
 
IR 3015 (w), 2823 (w), 1698 (s), 1640 (s), 1385 (s), 1278 (m), 1203 (m), 827 (s). 
 
HRMS (ESI) calcd for C6H7N2O2+ [M+H]+ 139.0502; found 139.0507. 
 
Tert-butyl 2,6-dioxo-3-vinyl-3,6-dihydropyrimidine-1(2H)-carboxylate (40). 
 
1-Vinyluracil (39) (0.25 g, 1.8 mmol, 1.0 eq), di-tert-butyl dicarbonate (0.78 g, 3.6 mmol, 2.0 
eq) and dimethylaminopyridine (0.44 g, 3.6 mmol, 2.0 eq) were stirred in acetonitrile (8.5 mL) 
for 12 h in a flame-dried flask under nitrogen. Silica and triethylamine (0.5 mL) were added to 
the reaction and the solvent was removed under reduced pressure. The dry residue was 
purified by column chromatography eluting with pentane/AcOEt mixture (2:8) as solvent. The 
pure product 40 (0.43 g, 1.8 mmol, quantitative yield) was obtained as a yellow oil. 
 
RF (AcOEt/pentane (1:1)) = 0.40. 
 
1H NMR (400 MHz, Chloroform-d) δ 7.51 (d, J = 8.2 Hz, 1H, uracil CH), 7.15 – 7.02 (m, 1H, 
vinyl-CH), 5.80 (d, J = 8.2 Hz, 1H, uracil CH), 5.14 (dd, J = 16.0, 2.4 Hz, 1H, vinyl-CH2), 4.96 
(dd, J = 9.0, 2.5 Hz, 1H, vinyl-CH2), 1.55 (s, 9H, Boc). 
 
13C NMR (101 MHz, Chloroform-d) δ 160.0, 147.5, 147.4, 138.6, 129.5, 103.0, 102.5, 87.0, 
27.4. 
 
IR 3104 (w), 2984 (w), 1783 (s), 1673 (s), 1440 (m), 1372 (s), 1280 (s), 1144 (s), 803 (m). 
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HRMS (ESI) calcd for C11H14N2NaO4+ [M+Na]+ 261.0846; found 261.0859. 
 
Dimethyl 2-(3-(tert-butoxycarbonyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-
yl)cyclopropane-1,1-dicarboxylate (41). 
 
 
 
Diazomalonate 32 (0.28 g, 1.8 mmol, 1.0 eq), Rh2(esp)2 (2.7 mg, 3.5 µmol, 0.02 mol%) and 
product 40 (0.42 g, 1.8 mmol, 1.0 eq) were stirred at room temperature in DCM (18 mL) in a 
flame-dried flask under nitrogen. After 2 hour. NEt3 (0.1 mL) and silica were added and the 
solvent was removed under reduced pressure. The dried residue was purified by column 
chromatography using a mixture of pentane/AcOEt (3:7) as eluting solvent. The pure 
cyclopropane 41 (0.56 g, 1.5 mmol, 87% yield) was obtained as a colorless foam. 
 
RF (AcOEt/pentane (1:1)) = 0.20.  
 
MP 45.0-46.2°C. 
 
1H NMR (400 MHz, Chloroform-d) δ 7.08 (d, J = 8.1 Hz, 1H, uracil CH), 5.64 (d, J = 8.2 Hz, 
1H, uracil CH), 3.98 (dd, J = 8.2, 6.5 Hz, 1H, cyclopropane-CH), 3.73 (s, 3H, ester CH3), 3.65 
(s, 3H, ester CH3), 2.19 (t, J = 6.6 Hz, 1H, cyclopropane-CH2), 1.88 (dd, J = 8.5, 6.8 Hz, 1H, 
cyclopropane-CH2), 1.51 (s, 9H, Boc). 
 
13C NMR (101 MHz, Chloroform-d) δ 167.5, 166.1, 160.2, 149.1, 147.2, 142.4, 101.9, 87.0, 
53.3, 53.2, 43.0, 34.9, 27.4, 19.8. 
 
IR 1780 (w), 1723 (m), 1676 (s), 1435 (w), 1312 (m), 1145 (s), 733 (s). 
 
HRMS (ESI) calcd for C16H20N2NaO8+ [M+Na]+ 391.1112; found 391.1106. 
 
 2.4 5-Fluoro-uracil cyclopropane. 
5-Fluoro-1-vinylpyrimidine-2,4(1H,3H)-dione (43). 
 
Palladium acetate (0.013 g, 0.056 mmol, 0.04 eq), vinyl acetate (1.7 mL, 3.4 mmol, 2.4 eq), 
fluoro-uracil 42 (0.18 g, 1.4 mmol, 1.0 eq), TMSOTf (0.60 mL, 3.4 mmol, 2.4 eq) and 
triethylamine (0.47 mL, 3.4 mmol, 2.4 eq) were stirred in DMF (4 mL) for 16 hours at 70 °C in 
a flame-dried sealed flask under nitrogen atmosphere. Then the reaction mixture was cooled 
down to room temperature and filtered on celite with AcOEt (50 mL). The crude mixture was 
concentrated under reduced pressure and purified by column chromatography, eluting with 
pentane and AcOEt mixture (1:1) to obtain the pure product 43 (0.12 g, 0.58 mmol, 57% 
yield) as a white solid. 
 
RF (AcOEt/pentane (6:4)) = 0.51. 
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MP 135.1-137.0°C. 
 
1H NMR (400 MHz, Chloroform-d) δ 7.52 (d, J = 5.8 Hz, 1H, F-uracil vinyl-CH ), 7.12 (ddd, J 
= 15.9, 9.1, 1.8 Hz, 1H, vinyl-CH), 5.11 – 4.79 (m, 2H, vinyl-CH2). 
 
13C NMR (101 MHz, Chloroform-d) δ 156.1 (d, J = 27.3 Hz), 147.3, 141.1 (d, J = 241.8 Hz), 
129.3, 123.1 (d, J = 34.2 Hz), 101.3. 
 
IR 3031 (w), 2844 (w), 1661 (s), 1377 (s), 1268 (s), 1122 (s), 970 (m), 913 (m). 
 
HRMS (ESI) calcd for C6FH6N2O2+ [M+H]+ 157.0408; found 157.0414. 
 
3-Benzoyl-5-fluoro-1-vinylpyrimidine-2,4(1H,3H)-dione (44). 
 
In a flame-dried flask under nitrogen, 1-vinyl-fluorouracil (43) (0.12 g, 0.79 mmol, 1.0 eq) was 
stirred with pyridine (2 mL), and added dropwise over 10 min to a solution of benzoyl chloride 
(0.34 g, 2.4 mmol, 3 eq) in pyridine (0.7 mL) and stirred for 2 h at room temperature. Then 
the crude mixture was partitioned between water (10 mL) and AcOEt (10 mL). The aqueous 
layer was extracted three times with AcOEt (10 mL) and the organic layers were dried over 
anhydrous MgSO4. The solvent was removed under reduced pressure and the dry residue 
was purified by column chromatography using a mixture of pentane/AcOEt (7:3 to 1:1) as 
eluting solvent. The pure product 44 (0.15 g, 0.58 mmol, 73% yield) was obtained as a white 
solid. 
 
RF (AcOEt/pentane (1:1)) = 0.54. 
 
MP 128.6-129.3°C. 
 
1H NMR (400 MHz, Chloroform-d) δ 7.95 (dd, J = 8.3, 1.4 Hz, 2H, Ar-H), 7.75 – 7.64 (m, 2H, 
Ar-H and F-uracil vinyl-CH), 7.52 (t, J = 7.9 Hz, 2H, Ar-H), 7.12 (ddd, J = 15.9, 9.0, 1.8 Hz, 
1H, vinyl-CH), 5.13 (dd, J = 15.8, 2.7 Hz, 1H, vinyl-CH2), 4.99 (dd, J = 9.0, 2.8 Hz, 1H, vinyl-
CH2). 
 
13C NMR (101 MHz, Chloroform-d) δ 166.8, 155.8 (d, J = 27.5 Hz), 146.8, 140.6 (d, J = 242.6 
Hz), 135.7, 130.7, 130.6, 129.4, 129.0, 123.6 (d, J = 34.2 Hz), 102.2. 
 
IR 1756 (m), 1665 (s), 1448 (w), 1368 (s), 1276 (m), 1229 (m), 909 (m). 
 
HRMS (ESI) calcd for C13H9FN2NaO3+ [M+Na]+ 283.0489; found 283.0485. 
 
Dimethyl 2-(3-benzoyl-5-fluoro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)cyclopropane-
1,1-dicarboxylate (45). 
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Diazomalonate 32 (0.21 g, 1.3 mmol, 1.2 eq), Rh2(esp)2 (0.002 g, 0.002 mmol, 0.02 mol%) 
and product 44 (0.29 g, 0.11 mmol, 1.0 eq) were stirred at room temperature in DCM (11 mL) 
in a flame-dried flask under nitrogen. After 1 hour, NEt3 (0.1 mL) and silica were added and 
the solvent was removed under reduced pressure. The dried residue was purified by column 
chromatography using a mixture of pentane/AcOEt (3:7) as eluting solvent. The pure 
cyclopropane 45 (0.40 g, 1.0 mmol, 93% yield) was obtained as a white foamy solid. 
 
RF (AcOEt/pentane (3:7)) = 0.33. 
 
MP 62.7-64.4°C. 
 
1H NMR (400 MHz, Chloroform-d) δ 7.85 – 7.78 (m, 2H, Ar-H), 7.62 – 7.55 (m, 1H, Ar-H), 
7.45 – 7.39 (m, 2H, Ar-H), 7.32 (d, J = 5.6 Hz, 1H, F-uracil vinyl-CH), 3.89 (dd, J = 8.0, 6.3 
Hz, 1H, cyclopropane-CH), 3.68 (s, 3H, ester CH3), 3.58 (s, 3H, ester CH3), 2.09 (t, J = 6.5 
Hz, 1H, cyclopropane-CH), 1.91 (dd, J = 8.1, 6.6 Hz, 1H, cyclopropane-CH). 
 
13C NMR (101 MHz, Chloroform-d) δ 167.1, 166.7, 156.0 (d, J = 27.2 Hz), 148.7, 139.7 (d, J 
= 240.3 Hz), 135.6, 130.8, 130.7, 129.2, 128.0 (d, J = 33.7 Hz), 53.3, 53.3, 42.9, 34.8, 20.3. 
 
One C=O of methyl-ester is not resolved. 
 
IR 3084 (w), 2953 (w), 1755 (m), 1717 (s), 1440 (m), 1296 (s), 1227 (s), 911 (m), 729 (s). 
 
HRMS (ESI) calcd for C18H15FN2NaO7+ [M+Na]+ 413.0755; found 413.0763. 
 
The crystal structure has been deposited at the Cambridge Crystallographic Data Centre and 
allocated the deposition number: CCDC 99618. 
 
 2.5 Dipolarophiles. 
Triisopropyl((1-phenylvinyl)oxy)silane (17). 
 
Following the reported procedure of Waser et al.,[1] acetophenone (16) (1.0 g, 8.3 mmol, 1 
eq) was solubilized in DCM (8 mL) and triethylamine (1,73 mL, 12,5 mmol, 1.5 eq) was 
added at room temperature. Then at 0 °C triisopropylsilyl trifluoromethanesulfonate (2,7 ml, 
10 mmol, 1.2 eq) was added dropwise and the reaction mixture was stirred at room 
temperature for 8 h. The solvent was evaporated under a flow of nitrogen. The crude product 
was purified by column chromatography, eluting with pentane and NEt3 1% to obtain the pure 
enol-ether 17 (2.0 g, 7.2 mmol, 86% yield) as a colorless oil. 
 
1H NMR (400 MHz, Chloroform-d) δ 7.70 – 7.64 (m, 2H, Ar-H), 7.41 – 7.27 (m, 3H, Ar-H), 
4.87 (d, J = 1.8 Hz, 1H, C=CH2), 4.44 (d, J = 1.9 Hz, 1H, C=CH2), 1.33 (m, 3H, TIPS-CH), 
1.16 (m, 18H, TIPS-CH3). 
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1H NMR values correspond to the literature.[1] 
 
(Z)-Triisopropyl((1-phenylprop-1-en-1-yl)oxy)silane (47). 
 
Following the reported procedure of Waser et al,[1] propiophenone (46) (0.50 mL, 3.7 mmol, 
1eq) was solubilized in THF (15 mL) at -78°C and NaHMDS (2M solution in THF, 2.1 mL, 4.1 
mmol, 1.1 eq) was added dropwise. The mixture was stirred 1 hour at room temperature and 
cooled down to -78 °C. TIPS-Cl (0.86 mL, 4.1 mmol, 1.1 eq) was added dropwise and the 
reaction mixture was stirred at room temperature for 8 h. The solvent was evaporated and 
the crude product was purified by column chromatography, eluting with pentane and NEt3 1% 
to obtain the pure enol-ether 47 (0.46 g, 1.6 mmol, 43% yield) as a slightly yellow oil. 
 
1H NMR (400 MHz, Chloroform-d) δ 7.50 – 7.38 (m, 2H, Ar-H), 7.33 – 7.18 (m, 3H, Ar-H), 
5.06 (q, J = 6.8 Hz, 1H, C=C), 1.77 (d, J = 6.9 Hz, 3H, CH3), 1.15 – 0.97 (m, 21H, TIPS). 
 
1H NMR values correspond to the literature.[1] 
 
((1-(4-Fluorophenyl)vinyl)oxy)triisopropylsilane (49). 
 
Following the reported procedure of Waser et al,[1] (4-fluorophenyl)ethanone (48) (0.44 mL, 
3.6 mmol, 1eq) was solubilized in THF (15 mL) at -78°C and NaHMDS (2M solution in THF, 
2.1 mL, 4.1 mmol, 1.1 eq) was added dropwise. The mixture was stirred 1 hour at room 
temperature and cooled down to -78°C. TIPS-Cl (0.86 mL, 4.1 mmol, 1.1 eq) was added 
dropwise and the reaction mixture was stirred at room temperature for 8 h. The solvent was 
evaporated and the crude product was purified by column chromatography, eluting with 
pentane and NEt3 1% to obtain the pure enol-ether 49 (0.62 g, 2.1 mmol, 58% yield) as a 
slightly yellow oil. 
 
1H NMR (400 MHz, Chloroform-d) δ 7.61 (dd, J = 8.9, 5.4 Hz, 2H, Ar-H), 7.00 (t, J = 8.8 Hz, 
2H, Ar-H), 4.77 (d, J = 1.9 Hz, 1H, C=CH), 4.39 (d, J = 1.9 Hz, 1H, C=CH), 1.39 – 1.20 (m, 
3H, TIPS-CH), 1.34-1.12 (m, 18H, TIPS-CH3 ).  
 
1H NMR values correspond to the literature.[1] 
 
(E)-Triisopropyl((4-phenylbuta-1,3-dien-2-yl)oxy)silane (51). 
 
Following the reported procedure of Waser et al.,[1] (E)-4-phenylbut-3-en-2-one (50) (0.42 g, 
2.9 mmol, 1 eq) was solubilized in DCM (3 mL) and triethylamine (0.60 mL, 4.3 mmol, 1.5 eq) 
was added at room temperature. Then triisopropylsilyl trifluoromethanesulfonate (0.93 mL, 
3.4 mmol, 1.2 eq) was added at 0 °C dropwise and the reaction mixture was stirred at room 
temperature for 8 h. The solvent was evaporated under a flow of nitrogen. The crude product 
was purified by column chromatography, eluting with pentane and NEt3 1% to obtain the pure 
enol ether 51 (0.87 g, 2.9 mmol, quantitative yield) as a colorless oil. 
 
RF (pentane) = 0.88. 
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1H NMR (400 MHz, Chloroform-d) δ 7.64 – 7.54 (m, 2H, Ar-H), 7.45 (m, 2H, Ar-H), 7.40 – 
7.32 (m, 1H, Ar-H), 7.15 (d, J = 15.6 Hz, 1H, C=CH), 6.74 (d, J = 15.7 Hz, 1H, C=CH), 4.61 – 
4.59 (s, 1H, C=CH2), 4.58 (s, 1H, C=CH2), 1.54 – 1.42 (m, 3H, TIPS-CH), 1.34 (d, J = 7.8 Hz, 
18H, TIPS-CH3). 
 
13C NMR (101 MHz, Chloroform-d) δ 155.6, 137.1, 129.4, 128.7, 127.8, 126.9, 126.7, 95.9, 
18.3, 13.1.  
 
IR 4319 (w), 4056 (w), 2945 (m), 2867 (m), 1638 (w), 1464 (m), 1327 (s), 1026 (s), 883 (s). 
 
HRMS (ESI) calcd for C19H31OSi+ [M+H]+ 303.2139; found 303.2140. 
 
3. Scope of the reaction. 
3.1 From thymine cyclopropanes. 
 (Cis)-dimethyl 5-(3-benzoyl-5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-
phenyldihydrofuran-3,3(2H)-dicarboxylate (8a) 
 
Following the described procedure of Benfatti et al.[6] a flame-dried microwave vial was 
loaded under nitrogen with FeCl3-Al2O3 (26 mg, 0.020 mmol, 5 mol %) and dimethyl 2-(3-
benzoyl-5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)cyclopropane-1,1-dicarboxylate 
(7a) (0.15 g, 0.39 mmol, 1.0 eq). Then, anhydrous DCM (1 mL) was added followed by 
benzaldehyde (0.059 mL, 0.58 mmol, 1.2 eq). The reaction mixture was stirred for 2 h at 
room temperature. After solvent removal under reduced pressure, the crude product was 
purified by column chromatography using a mixture of AcOEt/hexane (7:3) with 1% NEt3 as 
eluting solvent. The pure product 8a (0.15 g, 0.31 mmol, 80% yield) was obtained as a white 
solid. 
 
RF (AcOEt/hex (3:7)) = 0.27. 
 
MP 93.2-95.1 °C. 
 
1H NMR (400 MHz, Chloroform-d) δ 8.07 (d, J = 1.4 Hz, 1H, thymine vinyl-CH), 7.95 (dd, J = 
8.4, 1.4 Hz, 2H, Ar-H), 7.69 – 7.59 (m, 1H, Ar-H), 7.54 – 7.43 (m, 4H, Ar-H), 7.40 – 7.33 (m, 
3H, Ar-H), 6.36 (t, J = 7.5 Hz, 1H, tetrahydrofuran-NCH), 5.61 (s, 1H, tetrahydrofuran-CH), 
3.80 (s, 3H, ester methyl), 3.15 (s, 3H, ester methyl), 2.99 (dd, J = 14.5, 7.4 Hz, 1H, 
tetrahydrofuran-CH2), 2.80 (dd, J = 14.6, 7.7 Hz, 1H, tetrahydrofuran-CH2), 2.10 (d, J = 1.2 
Hz, 3H, thymine methyl). 
 
13C NMR (101 MHz, Chloroform-d) δ 169.8, 169.7, 168.8, 162.7, 149.5, 135.8, 135.2, 135.1, 
131.5, 130.5, 129.1, 128.8, 128.2, 126.5, 112.1, 82.5, 81.5, 63.8, 53.2, 52.8, 39.1, 13.0. 
 
IR 2736 (w), 1729 (m), 1673 (m), 1438 (m), 1278 (s), 1047 (s), 758 (s). 
 
                                                 
[7] F. Benfatti, F. de Nanteuil, J. Waser, Org. Lett. 2012, 14, 386–389. 
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HRMS (ESI) calcd for C26H24N2NaO8+ [M+Na]+ 515.1425; found 515.1435. 
 
(Cis)-Dimethyl 5-(3-(4-(tert-butyl)benzyl)-5-methyl-2,4-dioxo-3,4-dihydropyrimidin-
1(2H)-yl)-2-phenyldihydrofuran-3,3(2H)-dicarboxylate (8b) 
 
Following the described procedure of Benfatti et al.[7] a flame-dried microwave vial under 
nitrogen was loaded with FeCl3-Al2O3 (3.5 mg, 0.0035 mmol, 5 mol %) and dimethyl 2-(3-(4-
(tert-butyl)benzyl)-5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)cyclopropane-1,1-
dicarboxylate (7b) (0.03 g, 0.07 mmol, 1.0 eq). Then, anhydrous dichloromethane (1 mL) 
followed by benzaldehyde (10 µl, 0.10 mmol, 1.5 eq) were added. The mixture was stirred for 
2 h at room temperature. Afterwards, it was concentrated under reduced pressure with silica 
and NEt3 (0.3 mL). The dried residue was purified by column chromatography using a mixture 
of hexane/ethylacetate (7:3) with 1% NEt3 as eluting solvent. The pure product 8b (20 mg, 
0.040 mmol, 55% yield) was obtained as a white solid. 
 
RF (AcOEt/hex (3:7)) = 0.37. 
 
1H NMR (400 MHz, Chloroform-d) δ 7.87 (d, J = 1.6 Hz, 1H, thymine vinyl-CH), 7.47 – 7.39 
(m, 4H, Ar-H), 7.37 – 7.28 (m, 5H, Ar-H), 6.40 (t, J = 7.6 Hz, 1H, tetrahydrofuran-NCH), 5.60 
(s, 1H, tetrahydrofuran-OCH), 5.11 (s, 2H, benzylic-CH2), 3.80 (s, 3H, ester-methyl), 3.12 (s, 
3H, ester methyl), 2.92 (dd, J = 14.5, 7.6 Hz, 1H, tetrahydrofuran-CH2), 2.76 (dd, J = 14.5, 
7.5 Hz, 1H, tetrahydrofuran-CH2), 2.06 (d, J = 1.2 Hz, 3H,thymine-CH3), 1.28 (s, 9H, 
tBu). 
 
13C NMR (101 MHz, Chloroform-d) δ 170.0, 169.7, 163.3, 151.2, 150.5, 135.4, 133.9, 133.8, 
129.02, 128.7, 128.1, 126.5, 125.3, 111.4, 82.3, 82.2, 63.8, 53.1, 52.7, 44.3, 39.1, 34.5, 31.3, 
13.6. 
 
IR 3694 (w), 2975 (s), 2892 (m), 1687 (s), 1393 (m), 1258 (s), 1071 (s), 889 (w). 
 
HRMS (ESI) calcd for C30H34N2NaO7+ [M+Na]+ 557.2258; found 557.2266. 
 
General procedures for annulation reaction 
 
a) Conditions A 
Dimethyl 2-(3-(tert-butoxycarbonyl)-5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-
yl)cyclopropane-1,1-dicarboxylate (7c) (0.15 g, 0.40 mmol 1.0 eq), aldehyde (0.48 mmol, 1.2 
eq) and In(OTf)3 (0.045 g, 0.080 mmol, 0.2 eq) were stirred under nitrogen in a flame-dried 
sealed microwave vial with anhydrous DCM (2.0 mL) at room temperature for 2 h. Then, NEt3 
(0.9 mL) was added to quench the reaction and the crude mixture was concentrated under 
reduced pressure. After a rapid filtration on a silica plug with AcOEt and removal of the 
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solvent, the crude product was heated at 70 °C in EtOH (3 mL) in a sealed microwave vial for 
18 h. The mixture was concentrated under reduced pressure and purified by column 
chromatography with a gradient mixture of pentane/AcOEt from 7:3 up to 1:1 and the column 
was washed with straight AcOEt. 
b) Conditions B 
Dimethyl 2-(3-(tert-butoxycarbonyl)-5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-
yl)cyclopropane-1,1-dicarboxylate (7c) (0.15 g, 0.40 mmol 1.0 eq) and the ketone or sillylenol 
ether (0.48 mmol, 1.2 eq) were stirred under nitrogen in a flame-dried sealed microwave vial 
with anhydrous DCM (2.0 mL) and cooled down to -20 °C. Then, a 0.43 M tin(IV) chloride 
solution (0.09 mL, 0.04 mmol, 0.1 eq) was added and the reaction mixture was stirred for 2 h 
at -20 °C. NEt3 (0.9 mL) was added at -20 °C to quench the reaction and the reaction mixture 
was allowed to reach room temperature. The crude mixture was concentrated under reduced 
pressure. After a rapid filtration on a silica plug with AcOEt and removal of the solvent, the 
crude product was heated at 70 °C in EtOH (3 mL) in a sealed microwave vial for 18 h. The 
mixture was concentrated under reduced pressure and purified by column chromatography 
with a gradient mixture of pentane/AcOEt from 7:3 up to 1:1 and the column was washed 
with straight AcOEt. 
 
Dimethyl-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-phenyldihydrofuran-
3,3(2H)-dicarboxylate (8c). 
 
Following the conditions A, using benzaldehyde (0.051 g, 0.48 mmol, 1.2 eq), the pure 
product 8c (0.14 g, 0.35 mmol, 87% yield) was obtained as a white foamy solid. 
 
RF (pent/AcOEt (1:1)) = 0.64.  
 
MP 206.9-208.1 °C. 
 
1H NMR (400 MHz, Chloroform-d) δ 8.47 (s, 1H, thymine NH), 7.94 (d, J = 1.6 Hz, 1H, 
thymine vinyl-CH), 7.48 – 7.40 (m, 2H, Ar-H), 7.40 – 7.27 (m, 3H, Ar-H), 6.37 (t, J = 7.6 Hz, 
1H, tetrahydrofuran-NCH), 5.61 (s, 1H, tetrahydrofuran-CH), 3.81 (s, 3H, ester methyl), 3.13 
(s, 3H, ester methyl), 2.95 (dd, J = 14.5, 7.6 Hz, 1H, tetrahydrofuran-CH2), 2.78 (dd, J = 14.5, 
7.7 Hz, 1H, tetrahydrofuran-CH2), 2.06 (d, J = 1.3 Hz, 3H, thymine methyl). 
 
13C NMR (101 MHz, Chloroform-d) δ 169.9, 169.8, 163.3, 150.4, 135.9, 135.3, 128.7, 128.1, 
126.5, 112.1, 82.4, 81.4, 63.8, 53.1, 52.7, 39.0, 12.8. 
 
IR 3192 (w), 3069 (w), 1729 (s), 1695 (s), 1512 (m), 1281 (s), 1225 (m), 1094 (m), 1054 (m), 
915 (m). 
 
 
HRMS (ESI) calcd for C19H20N2NaO7+ [M+Na]+ 411.1163; found 411.1168. 
 
Dimethyl-2-methyl-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-
phenyldihydrofuran-3,3(2H)-dicarboxylate (8d). 
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Following the conditions B, using acetophenone (16) (0.058 g, 0.48 mmol, 1.2 eq), the pure 
product 8d (0.15 g, 0.38 mmol, 94% yield) was obtained as a white solid. 
 
RF (AcOEt/pent (1:1)) = 0.36. 
 
MP 246.8-247.3°C. 
 
1H NMR (400 MHz, Chloroform-d) δ 8.59 (s, 1H, thymine NH), 8.18 (d, J = 1.7 Hz, 1H, 
thymine vinyl-CH), 7.72 – 7.65 (m, 2H, Ar-H), 7.38 – 7.24 (m, 3H, Ar-H), 6.43 (dd, J = 8.2, 5.6 
Hz, 1H, tetrahydrofuran-NCH), 3.79 (s, 3H, ester methyl), 3.16 (s, 3H, ester methyl), 3.11 
(dd, J = 15.0, 8.2 Hz, 1H, tetrahydrofuran-CH2) 2.77 (dd, J = 14.9, 5.5 Hz, 1H, 
tetrahydrofuran-CH2) 2.04 (d, J = 1.3 Hz, 3H, thymine methyl), 1.86 (s, 3H, tetrahydrofuran 
methyl). 
 
13C NMR (101 MHz, Chloroform-d) δ 170.4, 168.8, 163.6, 150.7, 140.5, 136.9, 127.9, 127.8, 
125.8, 110.9, 88.0, 80.7, 67.1, 52.8, 52.6, 39.6, 25.7, 12.8. 
 
IR 1733 (m), 1706 (m), 1663 (m), 1272 (s), 1207 (w), 1126 (w), 1077 (w). 
 
HRMS (ESI) calcd for C20H22NNaO7+ [M+Na]+ 425.1319; found 425.1320. 
 
 
Dimethyl-2-(4-fluorophenyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-
yl)dihydrofuran-3,3(2H)-dicarboxylate (8e). 
 
Following the conditions A, using 4-fluorobenzaldehyde (0.060 g, 0.48 mmol, 1.2 eq), the 
pure product 8e (0.13 g, 0.32 mmol, 79% yield) was obtained as a slightly yellow solid. 
 
RF (pent/AcOET (1:1)) = 0.63. 
 
MP 218.8-220.3 °C. 
 
1H NMR (400 MHz, Chloroform-d) δ 8.54 – 8.46 (m, 1H, thymine NH), 7.93 (d, J = 1.5 Hz, 
1H, thymine vinyl-CH), 7.49 – 7.39 (m, 2H, Ar-H), 7.10 – 6.99 (m, 2H, Ar-H), 6.37 (t, J = 7.6 
Hz, 1H, tetrahydrofuran-NCH), 5.56 (s, 1H, tetrahydrofuran-CH), 3.81 (s, 3H, ester methyl), 
3.20 (s, 3H, ester methyl), 2.93 (dd, J = 14.6, 7.5 Hz, 1H, tetrahydrofuran-CH2), 2.77 (dd, J = 
14.6, 7.8 Hz, 1H, tetrahydrofuran-CH2), 2.05 (d, J = 1.2 Hz, 3H, thymine methyl). 
 
13C NMR (101 MHz, Chloroform-d) δ 169.8, 162.9 (d, J = 249 Hz), 150.4, 135.8, 131.0 (d, J = 
3.2 Hz), 128.5 (d, J = 8.2 Hz), 128.4, 115.2 (d, J = 21.6 Hz), 115,0, 112.2, 81.7, 81.2, 63.6, 
53.2, 52.9, 38.8, 12.8. 
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IR 3192 (w), 3069 (w), 1729 (s), 1695 (s), 1512 (m), 1281 (s), 1225 (m), 1094 (m), 1054 (m), 
915 (m). 
 
HRMS (ESI) calcd for C19H19FN2NaO7+ [M+Na]+ 429.1068; found 429.1055. 
 
The crystal structure has been deposited at the Cambridge Crystallographic Data Centre and 
allocated the deposition number: CCDC 995573. 
 
 
Dimethyl 2-isopropyl-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-
yl)dihydrofuran-3,3(2H)-dicarboxylate (8f). 
 
 
Following the conditions A, using isobutyraldehyde (0.035 g, 0.48 mmol, 1.2 eq), the pure 
product 8f (0.11 g, 0.30 mmol, 75% yield) was obtained as a colorless foam. 
 
RF (AcOEt/pent (1:1)) = 0.42. 
 
MP 157.7-160.8 °C. 
 
1H NMR (400 MHz, Chloroform-d) δ 9.45 (s, 1H, N-H), 7.62 (d, J = 1.5 Hz, 1H, thymine vinyl-
CH), 6.12 (t, J = 7.1 Hz, 1H, tetrahydrofuran-NCH), 4.14 (d, J = 7.8 Hz, 1H, tetrahydrofuran-
OCH), 3.80 (s, 3H, ester methyl), 3.78 (s, 3H, ester methyl), 2.70 (dd, J = 14.5, 6.5 Hz, 1H, 
tetrahydrofuran-CH2), 2.63 (dd, J = 14.5, 7.6 Hz, 1H, tetrahydrofuran-CH2), 1.98 (d, J = 1.3 
Hz, 3H, thymine methyl), 1.92 (dt, J = 13.7, 7.0 Hz, 1H, iso-propyl C-H), 1.03 (t, J = 6.8 Hz, 
6H, iso-propyl CH3). 
 
13C NMR (101 MHz, Chloroform-d) δ 170.5, 170.1, 163.9, 150.7, 135.9, 111.1, 87.2, 81.4, 
60.6, 53.0, 41.3, 30.0, 20.1, 19.5, 12.7. 
 
IR 3194 (w), 2960 (w), 2929 (w), 1730 (s), 1683 (s), 1468 (m), 1436 (m), 1275 (s), 1237 (m), 
1205 (m), 1081 (m), 916 (m), 733 (s). 
 
HRMS (ESI) calcd for C16H23N2O7+ [M+H]+ 355.1500; found 355.1502. 
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Dimethyl-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-((E)-
styryl)dihydrofuran-3,3(2H)-dicarboxylate. (8g) 
 
 
 
Following the conditions A, using cinnamaldehyde (0.063 g, 0.48 mmol, 1.2 eq), a mixture of 
diastereoisomers (5:1 by integration of methyl esters at 3.76 ppm and 3.71 ppm) 8g (0.16 g, 
0.28 mmol, 96% yield) was obtained as a colorless foam. 
 
RF (pent/AcOET (1:1)) = 0.67 
 
1H NMR (400 MHz, Chloroform-d) δ 8.82 (s, 1H, NH), 7.70 (d, J = 1.3 Hz, 1H, thymine vinyl-
CH, major diastereoisomer), 7.35 – 7.17 (m, 10H, Ar-H, both diastereoisomers), 7.14 (d, J = 
1.3 Hz, 1H, thymine vinyl-CH, minor diastereoisomer), 6.72 (dd, J = 16.0, 1.3 Hz, 1H vinyl C-
H, major and minor diastereoisomers), 6.20 (t, J = 7.3 Hz, 1H, tetrahydrofuran-NCH, major 
diastereoisomer), 6.16-6.05 (m, 2H, vinyl C-H and tetrahydrofuran-NCH, minor 
diastereoisomer), 6.11(dd, J = 16.0, 6.2 Hz, 1H, vinyl C-H, major diastereoisomer), 5.49 (dd, 
J = 6.2, 1.4 Hz, 1H, tetrahydrofuran-CH, minor diastereoisomer), 5.04 (dd, J = 6.3, 1.4 Hz, 
1H, tetrahydrofuran-CH2, major diastereoisomer), 3.76 (s, 3H, ester methyl, major 
diastereoisomer), 3.71 (s, 3H, ester methyl, minor diastereoisomer), 3.59 (s, 6H, ester 
methyl, minor and major diastereoisomers), 3.24 (dd, J = 14.3, 6.8 Hz, 1H, tetrahydrofuran-
CH2, minor diastereoisomer), 2.82 – 2.69 (m, 2H, tetrahydrofuran-CH2, major 
diastereoisomer), 2.58 (dd, J = 14.3, 5.4 Hz, 1H, tetrahydrofuran-CH2, minor 
diastereoisomer), 1.93 (d, J = 1.3 Hz, 3H, thymine methyl, major diastereoisomer), 1.88 (d, J 
= 1.2 Hz, 3H, thymine methyl minor diastereoisomer). 
 
13C NMR (101 MHz, Chloroform-d) δ 169.6, 169.5, 169.1, 169.1, 168.1, 163.6, 150.5, 150.1, 
135.9, 133.7, 133.2, 128.7, 128.4, 128.3, 126.7, 126.7, 123.1, 122.3, 111.7, 110.7, 83.8, 
82.2, 81.5, 64.1, 62.8, 53.3, 53.2, 53.1, 39.7, 38.9, 12.8, 12.6. 
One carbon of the major diastereoisomer in the aromatic region is unresolved. 
Six carbons of the minor diastereoisomer are unresolved. 
 
IR 3201 (w), 3073 (w), 2953 (w), 1731 (s), 1688 (s), 1468 (m), 1435 (m), 1284 (s), 1085 (s), 
972 (m), 913 (m), 734 (s). 
 
 
HRMS (ESI) calcd for C21H23N2O7+ [M+H]+ 415.1500; found 415.1502. 
Dimethyl-2-(4-fluorophenyl)-2-methyl-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-
1(2H)-yl)dihydrofuran-3,3(2H)-dicarboxylate (8h). 
 
Following the conditions B, using 4-fluoroacetophenone (48) (0.067 g, 0.48 mmol, 1.2 eq), 
the pure product 8h (0.16 g, 0.37 mmol, 93% yield) was obtained as a white solid. 
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RF (AcOEt/pent (1:1)) = 0.40. 
 
MP 248.8-250.2 °C. 
 
1H NMR (400 MHz, DMSO-d6) δ 11.47 (s, 1H, thymine NH), 8.07 (d, J = 1.5 Hz, 1H, thymine 
vinyl-CH), 7.70 – 7.60 (m, 2H, Ar-H), 7.20 (t, J = 8.9 Hz, 2H, Ar-H), 6.36 (dd, J = 8.3, 5.5 Hz, 
1H, tetrahydrofuran-NCH), 3.75 (s, 3H, ester methyl), 3.26 (dd, J = 14.9, 8.3 Hz, 1H, , 
tetrahydrofuran-CH2), 3.13 (s, 3H, ester methyl), 2.71 (dd, J = 14.9, 5.6 Hz, 1H, , 
tetrahydrofuran-CH2), 1.87 (d, J = 1.2 Hz, 3H, thymine methyl), 1.79 (s, 3H, tetrahydrofuran 
methyl). 
 
13C NMR (101 MHz, DMSO-d6) δ 170.6, 168.9, 164.1, 161.9 (d, J = 243.9 Hz), 151.1, 137.4 
(d, J = 3.0 Hz), 136.7, 128.4 (d, J = 8.2 Hz), 114.9 (d, J = 21.3 Hz), 109.9, 87.1, 80.6, 67.2, 
53.3, 53.0, 38.5, 25.9, 13.2. 
 
IR 3221 (w), 3072 (w), 2948 (w), 1513 (m), 1439 (w), 1269 (s), 1128 (m), 1077 (m), 964 (w), 
913 (m), 842 (m). 
 
HRMS (ESI) calcd for C20FH22N2O7+ [M+H]+ 421.1406; found 421.1405. 
 
Dimethyl-2-methyl-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-
phenethyldihydrofuran-3,3(2H)-dicarboxylate (8i). 
 
 
Following the conditions B, using 4-phenylbutan-2-one (0.071 g, 0.48 mmol, 1.2 eq), the pure 
product 8i (0.15 g, 0.34 mmol, 85% yield) was obtained as a slightly yellow solid. 
 
MP 167.9-168.7 °C. 
 
RF (pent/AcOET (1:1)) = 0.19. 
 
1H NMR (400 MHz, Chloroform-d) δ 8.07 (s, 1H, thymine NH), 7.74 (q, J = 1.2 Hz, 1H, 
thymine vinyl-CH), 7.30 (dd, J = 8.5, 6.6 Hz, 2H, Ar-H), 7.24 – 7.17 (m, 3H, Ar-H), 6.18 (dd, J 
= 7.7, 5.3 Hz, 1H, tetrahydrofuran-NCH), 3.78 (s, 3H, ester methyl), 3.72 (s, 3H, ester 
methyl), 3.23 – 3.05 (m, 1H, tetrahydrofuran-CH2), 2.92 – 2.69 (m, 2H, benzylic-CH2), 2.54 
(dd, J = 15.0, 5.4 Hz, 1H, tetrahydrofuran-CH2), 2.28 (ddd, J = 13.7, 11.7, 6.0 Hz, 1H, CH2), 
2.00 – 1.90 (m, 4H, thymine methyl and CH2), 1.47 (s, 3H, tetrahydrofuran methyl). 
 
13C NMR (101 MHz, Chloroform-d) δ 170.5, 168.9, 163.5, 150.3, 141.5, 136.6, 128.5, 128.3, 
126.1, 110.2, 87.0, 82.0, 66.2, 53.1, 52.9, 4.5, 38.8, 30.3, 21.9, 12.7. 
 
IR 3193 (w), 3060 (w), 2957 (w), 1735 (s), 1692 (s), 1468 (m), 1266 (s), 1097 (m), 914 (m). 
 
HRMS (ESI) calcd for C22H27N2O7+ [M+H]+ 431.1813; found 431.1802. 
 
The crystal structure has been deposited at the Cambridge Crystallographic Data Centre and 
allocated the deposition number: CCDC 994735 
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Dimethyl 2-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-1-oxaspiro[4.5]decane-
4,4-dicarboxylate. (8j) 
 
Following the conditions B, using cyclohexanone (0.047 g, 0.48 mmol, 1.2 eq), the pure 
product 8j (0.15 g, 0.39 mmol, 97% yield) was obtained as a colorless foamy solid. 
 
RF (AcOEt/pent (1:1)) = 0.3. 
 
MP 184.1-185.6 °C. 
 
1H NMR (400 MHz, Chloroform-d) δ 8.25 – 8.08 (br s, 1H, thymine NH), 7.70 (d, J = 1.5 Hz, 
1H, thymine vinyl-CH), 6.03 (dd, J = 7.6, 5.2 Hz, 1H, tetrahydrofuran-NCH), 3.71 (s, 3H, ester 
methyl), 3.68 (s, 3H, ester methyl), 3.11 (dd, J = 14.9, 7.6 Hz, 1H, tetrahydrofuran-CH2), 2.39 
(dd, J = 14.9, 5.3 Hz, 1H, tetrahydrofuran-CH2), 1.91 (d, J = 1.2 Hz, 3H, thymine methyl), 
1.75 – 1.47 (m, 8H, cyclohexane C-H), 1.22 – 1.12 (m, 2H, cyclohexane C-H). 
 
13C NMR (101 MHz, Chloroform-d) δ 170.3, 168.7, 163.6, 150.3, 136.6, 109.9, 87.2, 82.0, 
65.8, 52.9, 52.8, 39.6, 32.4, 31.2, 25.0, 22.7, 21.5, 12.7. 
 
IR 3210 (w), 2931 (w), 2856 (w), 1733 (m), 1687 (s), 1437 (w), 1268 (m), 1201 (w), 1095 (m), 
911 (m), 729 (s). 
 
HRMS (ESI) calcd for C18H24N2NaO7 [M+Na] 403.1481; found 403.1488. 
 
Dimethyl 2-methyl-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-((E)-
styryl)dihydrofuran-3,3(2H)-dicarboxylate. (8k) 
 
Following the conditions B, using (E)-4-phenylbut-3-en-2-one (50) (0.070 g, 0.48 mmol, 1.2 
eq), a mixture of unseparable diastereoisomers (ratio 2:1 obtained by integration of methyl 
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esters at 3.64 ppm and 3.55 ppm) 8k (0.14 g, 0.34 mmol, 79% yield) was obtained as a 
colorless foam. 
 
RF (pent/AcOET (1:1)) = 0.4 
 
1H NMR (400 MHz, Chloroform-d) δ 9.19 (br.s, 1H, N-H), 7.84 (d, J = 1.3 Hz, 1H, , thymine 
vinyl-CH, major diastereoisomer), 7.59 (d, J = 1.3 Hz, 1H, , thymine vinyl-CH, minor 
diastereoisomer), 7.36 – 7.16 (m, 5H, Ar-H), 6.69 (d, J = 15.9 Hz, 1H, vinyl C-H, minor 
diastereomer), 6.65 (d, J = 16.1 Hz, 1H, vinyl C-H, major diastereomer), 6.39 (d, J = 16.1 Hz, 
1H, vinyl C-H, major diastereomer), 6.32 (d, J = 16.0 Hz, 1H, vinyl C-H, minor diastereomer), 
6.25 (m, 1H, tetrahydrofuran-NCH, major and minor diastereoisomers ), 3.75 (s, 3H, ester 
methyl, major diastereoisomer), 3.72 (s, 3H, ester methyl, minor diastereoisomer), 3.64 (s, 
3H, ester methyl, minor diastereoisomer), 3.55 (s, 3H, ester methyl, major diastereoisomer), 
3.13 (dd, J = 14.7, 7.1 Hz, 1H, , tetrahydrofuran-CH2, minor diastereoisomer), 3.09 (dd, J = 
14.9, 7.8 Hz, 1H, tetrahydrofuran-CH2, major diastereoisomer), 2.57 (dd, J = 14.9, 5.5 Hz, 1H, 
tetrahydrofuran-CH2, major diastereoisomer), 2.51 (dd, J = 14.8, 5.6 Hz, 1H, tetrahydrofuran-
CH2, minor diastereoisomer), 1.91 (d, J = 1.2 Hz, 3H, thymine methyl, minor diastereoisomer), 
1.89 (d, J = 1.2 Hz, 3H, thymine methyl, major diastereoisomer), 1.61 (s, 3H, tetrahydrofuran 
methyl, minor diastereoisomer), 1.52 (s, 3H, tetrahydrofuran methyl, major diastereoisomer). 
 
13C NMR (101 MHz, Chloroform-d) δ 169.9, 169.4, 168.7, 168.5, 164.1, 164.0, 150.8, 150.5, 
136.7, 136.2, 136.0, 130.1, 129.8, 128.8, 128.7, 128.7, 128.7, 128.1, 126.7, 126.6, 110.4, 
109.8, 87.6, 86.4, 84.5, 82.2, 66.5, 66.4, 53.1, 53.1, 53.0, 39.6, 38.9, 24.9, 24.1, 12.8, 12.7. 
3 carbons are unresolved. 
 
IR 3180 (w), 3044 (w), 1736 (s), 1688 (s), 1458 (w), 1258 (s), 1076 (w), 733 (s). 
 
HRMS (ESI) calcd for C22H25N2O7+ [M+H]+ 429.1656; found 429.1660. 
 
Dimethyl-4-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-phenyl-2-
((triisopropylsilyl)oxy)cyclopentane-1,1-dicarboxylate. (9a) 
 
Following the conditions B, using TIPS protected acetophenone (17) (0.17 g, 0.60 mmol, 1.5 
eq), the pure product 9a (0.19 g, 0.33 mmol, 84% yield) was obtained as a white crystalline 
solid. 
 
RF (pent/AcOEt (1:1)) = 0.56. 
 
MP 81.8-83.2 °C. 
 
1H NMR (400 MHz, Chloroform-d) δ 8.40 (s, 1H, thymine N-H), 7.86 (d, J = 1.6 Hz, 1H, 
thymine vinyl-CH), 7.82 – 7.74 (m, 2H, Ar-H), 7.34 – 7.27 (m, 3H, Ar-H), 5.70 (ddd, J = 11.4, 
9.3, 5.7 Hz, 1H, cyclopentane-NCH), 3.76 (s, 3H, ester methyl), 3.29 (m, 4H, ester methyl 
and cyclopentane-CH2), 3.18 (t, J = 12.4 Hz, 1H, cyclopentane-CH2), 2.52 (dd, J = 12.8, 6.8 
Hz, 1H, cyclopentane-CH2), 2.36 (dd, J = 15.0, 7.3 Hz, 1H, cyclopentane-CH2), 2.00 (d, J = 
1.2 Hz, 3H, thymine methyl), 1.03 – 0.97 (m, 11H, TIPS), 0.97 – 0.90 (m, 10H, TIPS). 
 
13C NMR (101 MHz, Chloroform-d) δ 172.6, 168.1, 163.5, 151.1, 139.9, 137.3, 128.4, 128.1, 
127.4, 111.5, 88.3, 70.3, 52.7, 52.3, 51.5, 43.4, 38.2, 18.2, 13.8, 12.8. 
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IR 2950 (w), 2868 (w), 1681 (s), 1467 (m), 1434 (w), 1392 (w), 1259 (s), 1135 (m), 1090 (m). 
 
HRMS (ESI) calcd for C29H42N2NaO7Si+ [M+Na]+ 581.2653; found 581.2660. 
 
The crystal structure has been deposited at the Cambridge Crystallographic Data Centre and 
allocated the deposition number: CCDC 994948 
 
Dimethyl-2-(4-fluorophenyl)-4-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-
((triisopropylsilyl)oxy)cyclopentane-1,1-dicarboxylate. (9b) 
 
Following the conditions B, using ((1-(4-fluorophenyl)vinyl)oxy)triisopropylsilane (49) (0.14 g, 
0.48 mmol, 1.2 eq), the pure product 9b (0.18 g, 0.32 mmol, 80% yield) was obtained as a 
white foamy solid. 
 
 
MP 105.6-106.7 °C. 
 
RF (pent/AcOET (1:1)) = 0.45. 
 
1H NMR (400 MHz, Chloroform-d) δ 8.14 (d, J = 3.8 Hz, 1H, thymine-NH), 7.89 – 7.78 (m, 
3H, Ar-H and thymine vinyl-CH), 7.03 (t, J = 8.7 Hz, 2H, Ar-H), 5.71 (tt, J = 11.4, 7.0 Hz, 1H, 
cyclopentane-NCH), 3.79 (s, 3H, methyl ester), 3.37 (s, 3H, ester methyl), 3.36 – 3.31 (m, 
1H, cyclopentane-CH2). 3.19 (t, J = 12.3 Hz, 1H, cyclopentane-CH2), 2.54 (dd, J = 12.8, 6.8 
Hz, 1H, cyclopentane-CH2), 2.38 (dd, J = 15.1, 7.2 Hz, 1H, cyclopentane-CH2), 2.03 (d, J = 
1.2 Hz, 3H, thymine methyl), 1.39 – 1.23 (m, 3H, TIPS), 1.09 – 0.85 (m, 18H, TIPS). 
 
13C NMR (101 MHz, Chloroform-d) δ 172.6, 168.1, 162.7 (d, J = 246.7 Hz), 163.3, 151.0, 
137.2, 135.9 (d, J = 3.2 Hz), 130.2 (d, J = 8.1 Hz), 114.2 (d, J = 21.3 Hz), 111.6, 87.7, 70.2, 
52.8, 52.4, 51.4, 43.5, 38.1, 18.2, 13.8, 12.8. 
 
IR 3196 (w), 2951 (w), 2869 (w), 1681 (s), 1513 (w), 1466 (w), 1260 (m), 1098 (m), 911 (m), 
731 (s). 
 
HRMS (ESI) calcd for C29FH42N2O7Si+ [M+H]+ 577.2740; found 577.2719. 
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Dimethyl-3-methyl-4-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-phenyl-2-
((triisopropylsilyl)oxy)cyclopentane-1,1-dicarboxylate. (9c) 
 
Following the conditions B, using triisopropyl((1-phenylprop-1-en-1-yl)oxy)silane (47) (0.14 g, 
0.48 mmol, 1.2 eq), the pure product 9c (0.18 g, 0.32 mmol, 79% yield) was obtained as a 
shiny foamy solid. The stereochemistry of the methyl was determined by NOE experiments. 
 
RF (pent/AcOET (1:1)) = 0.48. 
 
MP 127.4-128.3 °C. 
 
1H NMR (400 MHz, Chloroform-d) δ 8.06 (s, 1H, thymine NH), 8.01 (d, J = 1.5 Hz, 1H, 
thymine vinyl-CH), 7.73 – 7.66 (m, 2H, Ar-H), 7.39 – 7.25 (m, 3H, Ar-H), 5.36 (td, J = 11.4, 
6.8 Hz, 1H cyclopentane -NCH), 3.70 (s, 3H, ester methyl), 3.35 (dq, J = 13.6, 6.8 Hz, 1H, 
tetrahydrofuran-CH), 3.20 (s, 3H, ester methyl), 3.12 (dd, J = 15.1, 11.3 Hz, 1H, 
cyclopentane -CH2). 2.33 (dd, J = 15.1, 6.8 Hz, 1H, cyclopentane -CH2), 2.02 (d, J = 1.2 Hz, 
3H, thymine methyl), 1.56 (s, 3H, cyclopentane methyl), 1.24 (hept, J = 7.3 Hz, 3H, TIPS), 
1.12 – 0.94 (m, 18H, TIPS). 
 
13C NMR (101 MHz, Chloroform-d) δ 172.7, 168.1, 163.3, 151.5, 138.6, 137.5, 128.3, 128.2, 
127.4, 111.6, 90.9, 70.4, 56.7, 52.8, 45.2, 35.8, 18.9, 18.8, 15.2, 12.9, 10.6. 
 
IR 3175 (w), 2963 (w), 2870 (w), 1679 (m), 1468 (w), 1257 (m), 1079 (m), 1026 (m), 910 (m), 
731 (s). 
 
HRMS (ESI) calcd for C30H45N2O7Si+ [M+H]+ 573.2991; found 573.2992. 
 
Dimethyl 4-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-((E)-styryl)-2-
((triisopropylsilyl)oxy)cyclopentane-1,1-dicarboxylate. (9d) 
 
 
Following the conditions B, using (E)-triisopropyl((4-phenylbuta-1,3-dien-2-yl)oxy)silane (52) 
(0.15 g, 0.48 mmol, 1.2 eq), a mixture of unseparable diastereoisomers (ratio 13:1 by 
integration of the NC-H proton at 5.64 ppm and 4.88 ppm) 9d (0.13 g, 0.22 mmol, 55% yield) 
was obtained as a colorless foam. 
 
RF (pent/AcOET (1:1)) = 0.54 
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1H NMR (400 MHz, Chloroform-d, Major diastereoisomer) δ 8.58 (s, 1H, N-H), 7.77 (d, J = 
1.1 Hz, 1H, thymine vinyl-CH), 7.34 – 7.21 (m, 5H, Ar-H), 6.85 (d, J = 16.6 Hz, 1H, vinyl C-
H), 6.43 (d, J = 16.5 Hz, 1H, vinyl C-H), 5.64 (tt, J = 11.5, 6.8 Hz, 1H, cyclopentane-NCH), 
3.74 (s, 3H, ester methyl), 3.52 (s, 3H, ester methyl), 3.23 (dd, J = 15.1, 11.3 Hz, 1H, 
cyclopentane -CH2), 2.82 (t, J = 12.1 Hz, 1H cyclopentane -CH2), 2.30 (dd, J = 12.5, 7.0 Hz, 
1H, cyclopentane -CH2), 2.17 (dd, J = 15.1, 6.5 Hz, 1H, cyclopentane -CH2), 1.92 (d, J = 1.2 
Hz, 3H, thymine methyl), 1.18 (m, J = 1.5 Hz, 3H, TIPS), 1.01 (d, J = 2.5 Hz, 12H, TIPS), 
0.96 (dd, J = 3.4, 1.8 Hz, 6H, TIPS). 
 
13C NMR (101 MHz, Chloroform-d,  Major diastereoisomer) δ 172.4, 168.8, 163.7, 151.1, 
137.6, 136.1, 130.7, 128.8, 128.8, 128.2, 126.7, 111.5, 86.7, 69.9, 53.1, 52.6, 51.4, 41.1, 
37.1, 29.7, 18.2, 18.0, 13.1, 12.8. 
TIPS methyls are giving 2 differents signals(18.2 and 18.0).  
 
IR 2947 (w), 2868 (w), 1689 (m), 1465 (w), 1435 (w), 1260 (m), 1088 (w), 1017 (w), 976 (w), 
911 (m), 732 (s). 
 
HRMS (ESI) calcd for C31H45N2O7Si+ [M+H]+ 585.2991; found 585.3015. 
 
 3.2 From uracil cyclopropane.  
Dimethyl -5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-phenyldihydrofuran-3,3(2H)-
dicarboxylate (18a). 
 
Following the conditions A, using benzaldehyde (0.051 g, 0.48 mmol, 1.2 eq) and the 
corresponding cyclopropane 41 (0.15 g, 0.40 mmol, 1 eq), the pure product 18a (0.093 g, 
0.25 mmol, 62% yield) was obtained as a white powder. 
 
RF (AcOEt) = 0.65.  
 
MP 209.0-210.7°C. 
 
1H NMR (400 MHz, Chloroform-d) δ 9.07 (s, 1H, NH), 8.05 (d, J = 8.2 Hz, 1H, uracil CH), 
7.42 – 7.29 (m, 2H, Ar-H), 7.24 (m, 3H, Ar-H), 6.29 (t, J = 7.4 Hz, 1H, tetrahydrofuran N-CH), 
5.84 (d, J = 8.1 Hz, 1H, uracil CH), 5.52 (s, 1H, tetrahydrofuran-CH), 3.72 (s, 3H, ester CH3), 
3.03 (s, 3H, ester CH3), 2.83 (dd, J = 14.7, 7.2 Hz, 1H, tetrahydrofuran-CH2), 2.73 (dd, J = 
14.7, 7.8 Hz, 1H, tetrahydrofuran-CH2). 
 
13C NMR (101 MHz, Chloroform-d) δ 170.0, 169.7, 163.0, 150.5, 140.4, 135.1, 128.8, 128.1, 
126.5, 103.6, 82.6, 81.6, 63.8, 53.2, 52.8, 39.4. 
 
 IR 3100 (w), 2968 (w), 1727 (s), 1694 (s), 1459 (m), 1275 (s), 1077 (s), 1052 (s), 730 (s). 
  
HRMS (ESI) calcd for C18H18N2NaO7+ [M+Na]+ 397.1006; found 397.1004. 
 
Dimethyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methyl-2-phenyldihydrofuran-
3,3(2H)-dicarboxylate (18b). 
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Following the conditions B, using acetophenone (16) (0.058 g, 0.48 mmol, 1.2 eq) and the 
cyclopropane 41 (0.16 g, 0.40 mmol, 1 eq), the pure product 18b (0.12 g, 0.30 mmol, 76% 
yield) was obtained as a white powder. 
 
RF (AcOEt/pent (1:1)) = 0.2.  
 
MP 235.8-238.4°C. 
 
1H NMR (400 MHz, DMSO-d6) δ 11.44 (s, 1H, NH), 8.18 (d, J = 8.2 Hz, 1H, uracil CH), 7.71 – 
7.51 (m, 2H, ArH), 7.46 – 7.23 (m, 3H, ArH), 6.29 (dd, J = 8.2, 5.1 Hz, 1H, tetrahydrofurane 
N-CH), 5.81 (dd, J = 8.2, 2.2 Hz, 1H, uracil CH), 3.72 (s, 3H, ester CH3), 3.27 (dd, J = 14.8, 
8.2 Hz, 1H, tetrahydrofurane-CH2), 3.03 (s, 3H, ester CH3), 2.67 (dd, J = 14.8, 5.2 Hz, 1H, 
tetrahydrofurane-CH2), 1.80 (s, 3H, tetrahydrofurane-CH3). 
 
13C NMR (101 MHz, DMSO-d6) δ 170.6, 168.8, 163.6, 151.1, 141.1, 141.1, 128.2, 126.0, 
102.3, 87.9, 81.2, 67.0, 53.2, 52.9, 25.8. 
 
Two carbons are unresolved. 
 
IR 3163 (w), 3035 (w), 2953 (w), 2838 (w), 1735 (s), 1733 (s), 1673 (s), 1436 (m), 1385 (m), 
1263 (s), 1210 (s), 1072 (s), 767 (s). 
 
HRMS (ESI) calcd for C19H20N2NaO7
+ [M+Na]+ 411.1163; found 411.1168. 
 
Dimethyl-4-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-phenyl-2-
((triisopropylsilyl)oxy)cyclopentane-1,1-dicarboxylate (19). 
 
Following the conditions B, using TIPS protected acetophenone 17 (0.17 g, 0.60 mmol, 1.5 
eq) and the cyclopropane 41 (0.16 g, 0.40 mmol, 1 eq), the pure product 19 (0.18 g, 0.33 
mmol, 81% yield) was obtained as a colorless foam. 
 
RF (AcOEt/pent (1:1)) = 0.5.  
 
MP 67.7-77.0°C. 
 
1H NMR (400 MHz, Chloroform-d) δ 9.92 (s, 1H, NH), 8.11 (d, J = 8.1 Hz, 1H, uracil CH), 
7.85 – 7.65 (m, 2H, ArH), 7.30 (m, 3H, ArH), 5.86 (dd, J = 8.1, 2.2 Hz, 1H, uracil CH), 5.74 
(tt, J = 11.3, 7.0 Hz, 1H, cyclopentane N-CH), 3.76 (s, 3H ester methyl), 3.34 (dd, J = 15.1, 
11.1 Hz, 1H, cyclopentane CH2), 3.29 (s, 3H, ester methyl), 3.18 (t, J = 12.4 Hz, 1H, 
cyclopentane CH2), 2.55 (dd, J = 12.9, 6.8 Hz, 1H, cyclopentane CH2), 2.37 (dd, J = 15.1, 7.1 
Hz, 1H, cyclopentane CH2), 1.02-0.95 (m, 21H, TIPS). 
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13C NMR (101 MHz, Chloroform-d) δ 172.7, 168.1, 163.7, 151.4, 141.7, 139.8, 128.4, 128.0, 
127.4, 103.2, 88.3, 70.3, 52.8, 52.3, 51.5, 43.5, 38.2, 18.2, 18.2, 13.8. 
 
 
IR 3183 (w), 3060 (w), 2950 (w), 1686 (s), 1462 (m), 1261 (m), 1113 (w), 990 (w), 885 (w). 
 
HRMS (ESI) calcd for C28H40N2NaO7Si
+ [M+Na]+ 567.2497; found 567.2496. 
 
 3.3 From 5-fluoro-uracil cyclopropane. 
 
General procedure for Benzoyl removal. 
 
The crude product was dissolved in EtOH (2 mL) and stirred at room temperature for 2 hours 
with NH4OH (0.6 mL, 40 eq, 25%). The mixture was evaporated to dryness and directly 
submitted to the column chromatography using a gradient of solvent from pentane/AcOEt 
(7:3) up to (3:7). 
 
Dimethyl -5-(5-fluoro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-phenyldihydrofuran-
3,3(2H)-dicarboxylate (20a). 
 
Following the conditions A, using benzaldehyde (0.051 g, 0.48 mmol, 1.2 eq), and the 
corresponding cyclopropane 45 (0.16 g, 0.40 mmol, 1 eq), followed by the benzoyl 
deprotection, the pure product 20a (0.11 g, 0.29 mmol, 72% yield) was obtained as a white 
powder. 
 
RF (AcOEt/pentane (1:1)) = 0.60. 
 
MP 227.9-228.5°C. 
 
1H NMR (400 MHz, Chloroform-d) δ 9.22 (s, 1H, NH), 8.25 (d, J = 6.1 Hz, 1H, F-uracil CH), 
7.47 – 7.34 (m, 2H, ArH), 7.34 – 7.22 (m, 3H, ArH), 6.31 (ddd, J = 7.8, 6.9, 1.7 Hz, 1H, 
tetrahydrofuran N-CH), 5.53 (s, 1H, tetrahydrofuran CH), 3.74 (s, 3H, ester CH3), 3.08 (s, 3H, 
ester CH3), 2.80 (qd, J = 14.8, 7.4 Hz, 2H, tetrahydrofuran CH2). 
 
13C NMR (101 MHz, Chloroform-d) δ 169.9, 169.6, 156.6 (dd, J = 27.1, 8.7 Hz), 149.1 (d, J = 
7.7 Hz), 141.0 (d, J = 238.8 Hz), 134.8, 129.0, 128.2, 126.4, 124.7 (d, J = 34.8 Hz), 82.7, 
81.8, 63.6, 53.2, 53.0, 39.2. 
 
IR 3196 (w), 3071 (w), 2956 (w), 1723 (s), 1668 (m), 1436 (w), 1273 (s), 1211 (m), 1094 (m), 
1053 (m), 914 (m), 735 (m). 
 
HRMS (ESI) calcd for C18H17FN2NaO7 [M+Na] 415.0917; found 415.0918. 
 
Dimethyl -5-(5-fluoro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methyl-2-
phenyldihydrofuran-3,3(2H)-dicarboxylate (20b). 
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Following the conditions B, using acetophenone (16) (0.058 g, 0.48 mmol, 1.2 eq) and the 
corresponding cyclopropane 45 (0.16 g, 0.40 mmol, 1 eq) at -40 °C, followed by the benzoyl 
deprotection, the pure product 20b (0.12 g, 0.28 mmol, 71% yield) was obtained as a white 
powder. 
 
RF (AcOEt/pentane (1:1)) = 0.42. 
 
MP 209.3-210.2°C. 
 
1H NMR (400 MHz, Chloroform-d) δ 9.98 (d, J = 4.6 Hz, 1H, NH), 8.50 (d, J = 6.5 Hz, 1H, F-
uracil CH), 7.77 – 7.65 (m, 2H, ArH), 7.51 – 7.16 (m, 3H, ArH), 6.42 (ddd, J = 8.2, 5.1, 1.7 
Hz, 1H, tetrahydrofuran N-CH), 3.80 (s, 3H, ester CH3), 3.18 (dd, J = 15.1, 8.2 Hz, 1H, 
tetrahydrofuran CH2), 3.10 (s, 3H, ester CH3), 2.78 (dd, J = 15.1, 5.1 Hz, 1H, tetrahydrofuran 
CH2), 1.88 (s, 3H, CH3). 
 
13C NMR (101 MHz, Chloroform-d) δ 170.5, 168.6, 157.1 (d, J = 26.8 Hz), 149.6, 140.5 (d, J 
= 236.4 Hz), 140.0, 128.0, 127.9, 125.7, 125.6 (d, J = 35.1 Hz), 88.6, 81.4, 66.9, 52.9, 52.8, 
39.7, 25.7. 
 
IR 3173 (w), 3065 (w), 2954 (w), 1758 (w), 1718 (s), 1669 (s), 1485 (w), 1421 (w), 1262 (s), 
1205 (m), 1076 (s), 914 (m), 768 (m). 
 
HRMS (ESI) calcd for C19H19FN2NaO7 [M+Na] 429.1074; found 429.1080. 
 
Dimethyl -4-(5-fluoro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-phenyl-2-
((triisopropylsilyl)oxy)cyclopentane-1,1-dicarboxylate (21). 
 
Following the conditions B, using TIPS protected acetophenone 17 (0.17 g, 0.60 mmol, 1.5 
eq) and the corresponding cyclopropane 45 (0.16 g, 0.40 mmol, 1 eq) at -40 °C, followed by 
the benzoyl deprotection, the pure product 21 (0.12 g, 0.20 mmol, 51% yield) was obtained 
as a colorless oil. 
 
RF (AcOEt/pentane (1:1)) = 0.75. 
 
1H NMR (400 MHz, Chloroform-d) δ 9.96 (br. m., 1H, NH), 8.33 (d, J = 6.5 Hz, 1H, F-uracil 
CH), 7.76 (dd, J = 7.8, 2.0 Hz, 2H, ArH), 7.39 – 7.21 (m, 3H, ArH), 5.74 (dddd, J = 8.6, 6.5, 
4.6, 1.5 Hz, 1H, tetrahydrofuran N-CH), 3.74 (s, 3H, ester CH3), 3.39 – 3.29 (m, 1H, 
tetrahydrofuran CH2), 3.28 (s, 3H, ester CH3), 3.14 (dd, J = 13.0, 11.7 Hz, 1H, 
tetrahydrofuran CH2), 2.55 (dd, J = 12.9, 7.0 Hz, 1H, tetrahydrofuran CH2), 2.35 (dd, J = 15.2, 
6.7 Hz, 1H, tetrahydrofuran CH2), 1.01-0.94 (m, 21H, TIPS).  
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13C NMR (101 MHz, Chloroform-d) δ 172.8, 168.0, 157.0 (d, J = 26.5 Hz), 150.2, 141.0 (d, J 
= 237.5 Hz), 139.6, 128.5, 127.9, 127.4, 125.9 (d, J = 33.4 Hz), 88.4, 70.3, 52.9, 52.4, 52.0, 
43.4, 38.0, 18.2, 18.2, 13.9. 
 
IR 3194 (w), 3067 (w), 2951 (w), 2855 (w), 1718 (s), 1466 (w), 1256 (s), 1134 (m), 991 (m), 
788 (m), 740 (m). 
 
HRMS (ESI) calcd for C28H39FN2NaO7Si+ [M+Na]+ 585.2403; found 585.2386. 
 
 
4. Thymine based nucleoside analogues derivatizations. 
4.1 Acids. 
General procedure for hydrolysis and decarboxylation reaction 
 
 
Compound 8 (1 eq) and KOH (4 eq) were stirred under nitrogen in a dried and sealed 
microwave vial with dry methanol (0.06 mL) for 2 days at 70 °C. The thick yellow mixture was 
cooled down to room temperature and acidified with a 0.1 M HCl solution (0.5 mL). The 
mixture was extracted 3 times with AcOEt (2 mL), the organic layers were dried over 
anhydrous MgSO4 and concentrated under reduced pressure. The corresponding monoacid 
was obtained after column chromatography with a gradient of DCM to a solvent mixture of 
DCM/MeOH 8:2 and 1% AcOH. 
 
5-(5-Methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-phenyltetrahydrofuran-3-
carboxylic acid (52). 
 
Following the general procedure for hydrolysis and decarboxylation reaction, using 
compound 8c (0.050 g, 0.13 mmol, 1 eq) and KOH (29 mg, 0.52 mmol, 4 eq) in dry MeOH 
(0.3 mL), the pure monoacid 52 (0.034 g, 0.10 mmol, 83% yield) was obtained as a white 
solid. 
 
RF (AcOEt) = 0.23. 
 
MP 123.2-125.3°C. 
 
1H NMR (400 MHz, Methanol-d4) δ 7.37 (d, J = 8.6 Hz, 3H, Ar-H and thymine vinyl-CH), 7.32 
– 7.22 (m, 3H, Ar-H), 6.20 – 6.08 (m, 1H, tetrahydrofuran-NCH), 5.01 (d, J = 8.7 Hz, 1H, 
tetrahydrofuran-CH), 3.35 – 3.24 (m, 1H, tetrahydrofuran-CH), 2.68 (dt, J = 13.1, 8.1 Hz, 1H 
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tetrahydrofuran-CH2), 2.47 (ddd, J = 13.8, 9.5, 4.5 Hz, 1H, tetrahydrofuran-CH2), 1.78 (s, 3H, 
thymine methyl). 
 
13C NMR (101 MHz, Methanol-d4) δ 174.0, 165.0, 150.9, 138.9, 137.2, 128.2, 126.2, 110.4, 
85.7, 83.7, 49.9, 35.3, 11.0. 
The acid carbon is not defined. 
 
IR 3429 (w), 3211 (w), 3039 (w), 2529 (w), 1695 (s), 1475 (w), 1272 (m), 1068 (m), 769 (w), 
701 (m). 
 
HRMS (ESI) calcd for C16H16N2NaO5+ [M+Na]+ 339.0951; found 339.0944. 
 
.2-Methyl-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-
phenyltetrahydrofuran-3-carboxylic acid (53). 
 
Following the general procedure for hydrolysis and decarboxylation reaction, using 
compound 8d (0.020 g, 0.050 mmol, 1 eq) and KOH (6 mg, 0.1 mmol, 4 eq), the pure 
monoacid 53 (0.014 g, 0.042 mmol, 83% yield) was obtained as a white solid. The 
stereochemistry of the acid was determined by NOE experiment. 
 
RF (AcOEt) = 0.18. 
 
MP 236.2-236.7 °C. 
 
1H NMR (400 MHz, Acetone-d6) δ 11.39 (br s, 1H, COOH ), 10.01 (s, 1H, thymine NH), 7.70 
– 7.62 (m, 2H, Ar-H), 7.48 – 7.28 (m, 3H, Ar-H), 7.25 (q, J = 1.1 Hz, 1H, thymine vinyl-CH), 
6.46 (dd, J = 7.5, 4.2 Hz, 1H, tetrahydrofuran-NCH), 3.75 (t, J = 8.7 Hz, 1H, tetrahydrofuran-
CH), 2.99 (ddd, J = 14.1, 8.9, 7.6 Hz, 1H, tetrahydrofuran-CH2), 2.51 (ddd, J = 14.0, 8.7, 4.2 
Hz, 1H, tetrahydrofuran-CH2), 1.71 (d, J = 1.3 Hz, 3H, thymine methyl), 1.60 (s, 3H, 
tetrahydrofuran methyl). 
 
13C NMR (101 MHz, Acetone-d6) δ 177.8, 169.4, 156.0, 150.9, 142.1, 133.4, 132.6, 130.5, 
115.2, 92.0, 90.0, 57.2, 39.5, 30.0, 16.7. 
 
IR 3220 (w), 3054 (w), 2925 (w), 2854 (w), 1704 (s), 1660 (m), 1478 (w), 1419 (w), 1271 (w), 
1110 (w), 1058 (w), 855 (w), 800 (w), 769 (w). 
 
HRMS (ESI) calcd for C17H19N2O5+ [M+H]+ 331.1288; found 331.1281. 
 
5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-((E)-styryl)tetrahydrofuran-3-
carboxylic acid (54). 
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Following the general procedure for hydrolysis and decarboxylation reaction, using 
compound 8g (0.14 g, 0.34 mmol, 1 eq) and KOH (0.080 g, 1.4 mmol, 4.0 eq) in dry MeOH 
(1.4 mL). A mixture of unseparable monoacids (ratio 5:1 obtained by integration of the proton 
at 5.17 ppm and 4.76 ppm) 54 (82 mg, 0.24 mmol, 71% yield) was obtained as a white solid. 
 
RF diacid (DCM/MeOH (8:2) 1% AcOH) = 0.05. 
RF 56 (DCM/MeOH (8:2) 1% AcOH) = 0.2. 
 
1H NMR (400 MHz, Methanol-d4) δ 7.65 (s, 1H, thymine vinyl-CH, minor diastereoisomer), 
7.55 (s, 1H, thymine vinyl-CH, major diastereoisomer), 7.49 (d, J = 7.8 Hz, 4H, Ar-H, major 
and minor diastereoisomers), 7.40 – 7.25 (m, 6H, Ar-H, major and minor diastereoisomers), 
6.76 (d, J = 15.9 Hz, 2H, vinyl-CH, major and minor diastereoisomers), 6.48 (ddd, J = 16.1, 
7.2, 1.7 Hz, 1H, vinyl-CH, major diastereoisomer), 6.34 (ddd, J = 16.0, 6.7, 1.7 Hz, 1H, vinyl-
CH,  minor diastereoisomers), 6.26 – 6.17 (m, 2H, tetrahydrofuran-NCH, major and minor 
diastereoisomers), 5.17 (t, J = 7.0 Hz, 1H, tetrahydrofuran-CH, minor diastereoisomer), 4.76 
(t, J = 7.7 Hz, 1H, tetrahydrofuran-CH, major diastereoisomer), 3.25 (q, J = 8.9 Hz, 1H, 
tetrahydrofuran-CH, major diastereoisomer), 3.18 (q, J = 8.9 Hz, , tetrahydrofuran-CH, major 
diastereoisomer), 2.86 – 2.71 (m, 2H, , tetrahydrofuran-CH2, major and minor 
diastereoisomers), 2.47 (m, 2H, tetrahydrofuran-CH2, major and minor diastereoisomers), 
1.94 (s, 3H, thymine methyl, minor diastereoisomer), 1.92 (s, 3H, thymine methyl, major 
diastereoisomer). 
 
13C NMR (101 MHz, Methanol-d4) δ 175.1, 175.0, 166.5, 166.4, 152.4, 152.2, 138.1, 137.8, 
137.7, 137.6, 134.7, 133.6, 129.7, 129.7, 129.6, 129.2, 129.0, 128.5, 127.8, 127.7, 111.7, 
111.5, 87.7, 86.9, 84.9, 84.8, 49.6, 49.4, 49.2, 49.0, 48.8, 48.6, 48.4, 36.7, 36.5, 12.5. 
For the major diastereoisomer, the acid carbon is not define and an aromatic one neither. 
One carbon is missing for the minor diastereoisomer. 
 
IR 3442 (w), 3184 (w), 3031 (w), 2531 (w), 1684 (s), 1485 (w), 1407 (w), 1369 (w), 1271 (m), 
1204 (w), 1115 (w), 1072 (m), 980 (w), 751 (w), 695 (m). 
 
HRMS (ESI) calcd for C18H19N2O5+ [M+H]+ 343.1288; found 343.1294. 
 
 
2-(4-Fluorophenyl)-2-methyl-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-
yl)tetrahydrofuran-3-carboxylic acid (55). 
 
Following the general procedure for hydrolysis and decarboxylation reaction, using 
compound 8h (0.040 g, 0.095 mmol, 1 eq) and KOH (21 mg, 0.38 mmol, 4 eq) in a mixture of 
MeOH/water (0.1 mL/0.1 mL), a mixture of unseparable monoacids (ratio 10:1 obtained by 
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integration of the proton at 6.50 ppm and 6.40 ppm) 55 (0.028 g, 0.080 mmol, 84% yield) 
were obtained as a white solid. 
 
RF (DCM/MeOH (9:1)) = 0.15. 
 
MP 193.4-194.2 °C. 
 
1H NMR (400 MHz, Acetone-d6) δ 10.08 (br.s, 1H, COOH), 8.17 (s, 1H, NH), 7.68 (dd, J = 
8.1, 4.9 Hz, 2H, Ar-H, major diastereoisomer), 7.55 (dd, J = 8.0, 4.8 Hz, 2H, Ar-H, minor 
diastereoisomer), 7.30 (s, 1H, thymine vinyl-CH, major diastereoisomer), 7.13 (t, J = 8.3 Hz, 
2H, Ar-H, major diastereoisomer), 7.07 (t, J = 8.4 Hz, 2H, , Ar-H, minor diastereoisomer), 
6.50 (t, J = 7.0 Hz, 1H, , tetrahydrofuran-NCH, minor diastereoisomer), 6.40 (dd, J = 8.0, 3.9 
Hz, 1H, tetrahydrofuran-NCH, major diastereoisomer), 3.72 (t, J = 9.1 Hz, 1H, 
tetrahydrofuran-CH, major diastereoisomer), 3.46 (dd, J = 9.2, 4.1 Hz, 1H, tetrahydrofuran-
CH, minor diastereoisomer), 3.00 (dt, J = 13.4, 8.7 Hz, 1H, tetrahydrofuran-CH2, major 
diastereoisomer), 2.93 (dd, J = 15.4, 7.9 Hz, 1H, tetrahydrofuran-CH2, minor 
diastereoisomer), 2.53 (ddd, J = 13.7, 8.9, 3.9 Hz, 1H, tetrahydrofuran-CH2, major 
diastereoisomer), 2.46 – 2.35 (m, 1H, tetrahydrofuran-CH2, minor diastereoisomer), 1.80 (s, 
3H, thymine methyl, minor diastereoisomer), 1.74 (s, 3H, thymine methyl, major 
diastereoisomer). 
 
13C NMR (101 MHz, Acetone-d6) δ 174.7, 164.3, 164.2, 164.0, 162.8 (d, J = 244.1 Hz), 162.7 
(d, J = 244.1 Hz). 151.4, 151.3, 142.7 (d, J = 3.0 Hz), 139.6 (d, J = 2.9 Hz), 137.8, 137.5, 
128.5 (d, J = 8.1 Hz), 128.4 (d, J = 8.2 Hz), 115.5 (d, J = 21.4 Hz), 115.1 (d, J = 21.4 Hz), 
111.0, 110.9, 86.9, 86.9, 85.5, 83.2, 53.9, 53.2, 35.2, 34.9, 12.7, 12.3. 
 
IR 3530 (w), 3189 (w), 3065 (w), 2927 (w), 1697 (s), 1512 (m), 1268 (m), 1088 (w), 1052 (w), 
839 (m). 
 
HRMS (ESI) calcd for C17FH18N2O5+ [M+H]+ 349.1194; found 349.1194. 
 
 4.2 Alcohols. 
General procedure for reduction of carboxylic acids. 
 
 
The carboxylic acid (1 eq) was solubilized in dry THF in a dried round bottom flask under 
nitrogen. The reaction mixture under nitrogen was cooled to 0 °C and dimethylsulfide borane 
solution (2 M in THF, 0,042 mL, 0.083 mmol, 2.2 eq) was added dropwise. The reaction was 
allowed to slowly warm up and was stirred under nitrogen for 16 h. The reaction mixture was 
quenched by addition of a saturated solution of Na2CO3 (0.5 mL) and acidified by addition of 
a 1 M HCl solution (1 mL). Then the mixture was extracted three times with AcOEt (3 mL) 
and the organic layers were dried over anhydrous MgSO4. The crude product was purified by 
column chromatography with a gradient of pure AcOEt to a mixture of AcOEt/MeOH (8:2), 
affording the pure alcohol, as a colorless foam. 
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4-(Hydroxymethyl)-5-phenyltetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione 
(22). 
 
Following the general procedure for reduction of carboxylic acids, using compound 52 (0.012 
g, 0.038 mmol, 1 eq) and DMS solution (0.042 mL, 0.083 mmol, 2.2 eq) in dry THF (0.35 
mL), the alcohol 22 (0.0095 g, 0.031 mmol, 86% yield) was obtained as a colorless oil. 
 
RF (AcOEt) = 0.34. 
 
MP 68.1-69.4°C. 
 
1H NMR (400 MHz, Methanol-d4) δ 7.53 – 7.47 (m, 1H, thymine vinyl-CH), 7.49 – 7.28 (m, 
5H, Ar-H), 6.29 – 6.09 (m, 1H, tetrahydrofuran-NCH), 4.78 (d, J = 8.6 Hz, 1H , 
tetrahydrofuran-CH), 3.68 (dd, J = 11.2, 4.4 Hz, 1H , -CH2OH), 3.64 – 3.53 (dd, J = 11.2, 5.6 
Hz, 1H , -CH2OH), 2.61 (ddd, J = 14.2, 8.3, 2.8 Hz, 1H, tetrahydrofuran-CH), 2.49 (ddd, J = 
13.7, 8.7, 7.6 Hz, 1H, tetrahydrofuran-CH2), 2.35 (ddd, J = 13.6, 9.0, 4.5 Hz, 1H, 
tetrahydrofuran-CH2), 1.88 (d, J = 2.4 Hz, 3H, thymine methyl). 
 
13C NMR (101 MHz, Methanol-d4) δ 166.5, 152.6, 141.4, 138.4, 129.85, 129.5, 128.1, 111.9, 
86.7, 84.8, 62.3, 49.1, 35.9, 12.7. 
 
IR 3410 (w), 3207 (w), 2927 (w), 2520 (w), 1686 (s), 1471 (m), 1271 (m), 1055 (m), 911 (w), 
760 (m). 
 
HRMS (ESI) calcd for C16H18N2NaO4+ [M+Na]+ 325.1159; found 325.1159. 
 
 
4-(Hydroxymethyl)-5-methyl-5-phenyltetrahydrofuran-2-yl)-5-methylpyrimidine-
2,4(1H,3H)-dione (23). 
 
Following the general procedure for reduction of carboxylic acids, using compound 53 (0.018 
g, 0.054 mmol, 1 eq) and DMS solution (0.060 mL, 0.12 mmol, 2.2 eq) in dry THF (0.5 mL), 
the alcohol 23 (0.013 g, 0.041 mmol, 75% yield) was obtained as a colorless foam. 
 
RF (AcOEt) = 0.13. 
 
MP 79.4-83.4°C. 
 
1H NMR (400 MHz, Chloroform-d) δ 8.60 (s, 1H, thymine-NH), 7.46 (d, J = 7.6 Hz, 2H, Ar-H), 
7.39 – 7.22 (m, 3H, Ar-H), 6.82 (s, 1H, thymine vinyl-CH), 6.21 (d, J = 3.6 Hz, 1H, 
tetrahydrofuran-NCH), 3.96 (dd, J = 10.5, 5.4 Hz, 1H, -CH2OH), 3.74 (dd, J = 10.7, 7.9 Hz, 
1H, -CH2OH), 2.75 (dd, J = 11.0, 4.6 Hz, 1H, tetrahydrofuran-CH), 2.44 – 2.25 (m, 2H, 
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tetrahydrofuran-CH2), 2.04 (br.s, 1H, OH), 1.60 (s, 3H, thymine methyl), 1.42 (s, 3H, 
tetrahydrofuran methyl). 
 
13C NMR (101 MHz, Chloroform-d) δ 163.7, 150.4, 145.6, 136.3, 128.6, 127.7, 125.1, 110.3, 
87.6, 85.0, 62.6, 47.5, 36.6, 24.5, 12.5. 
 
IR 3446 (w), 2959 (w), 1679 (s), 1473 (w), 1448 (w), 1265 (m), 1031 (s), 911 (w), 767 (m), 
735 (m). 
 
HRMS (ESI) calcd for C17H20N2NaO4+ [M+Na]+ 339.1315; found 339.1317. 
 
4-(Hydroxymethyl)-5-((E)-styryl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-
dione (24). 
 
Following the general procedure for reduction of carboxylic acids, using the mixture of 
diastereoisomers 54 (0.020 g, 0.058 mmol, 1 eq) and DMS solution (0.063 mL, 0.13 mmol, 
2.2 eq) in dry THF (0.53 mL), the mixture of diastereoisomeric alcohols (ratio 5:1 obtained by 
integration of the proton at 4.42 ppm and 4.65 ppm) 24 (0.016 g, 0.049 mmol, 83% yield) 
was obtained as colorless oil. 
 
RF (DCM/MeOH (9.5:0.5)) = 0.25. 
 
1H NMR (400 MHz, Chloroform-d, major diastereoisomer) δ 8.24 (br.s, 1H, thymine-NH), 
7.40 – 7.20 (m, 6H, Ar-H and thymine vinyl-CH), 6.67 (d, J = 16.0 Hz, 1H, vinyl-CH), 6.24 
(dd, J = 15.8, 7.1 Hz, 1H, vinyl-CH), 6.07 (dd, J = 6.7, 3.6 Hz, 1H, tetrahydrofuran-NCH), 
4.42 (t, J = 7.5 Hz, 1H, tetrahydrofuran-CH), 3.74 (dd, J = 10.7, 5.0 Hz, 1H, -CH2OH), 3.68 
(dd, J = 10.7, 5.1 Hz, 1H, -CH2OH), 2.46 – 2.26 (m, 2H, tetrahydrofuran-CH2), 2.16 (ddd, J = 
12.1, 7.1, 3.5 Hz, 1H, tetrahydrofuran-CH), 1.86 (d, J = 1.2 Hz, 3H, thymine methyl). 
 
13C NMR (101 MHz, Chloroform-d, major diastereoisomer) δ 164.1, 150.6, 136.4, 136.0, 
134.5, 129.3, 129.0, 127.4, 127.3, 111.2, 86.2, 84.1, 62.7, 46.1, 36.3, 13.3. 
 
IR 2962 (w), 2924 (w), 2853 (w), 1687 (s), 1471 (w), 1363 (w), 1268 (m), 1189 (w), 1055 (s), 
967 (m), 744 (m). 
 
HRMS (ESI) calcd for C18H20N2NaO4+ [M+Na]+ 351.1315; found 351.1319. 
 
 
5-(4-Fluorophenyl)-4-(hydroxymethyl)-5-methyltetrahydrofuran-2-yl)-5-
methylpyrimidine-2,4(1H,3H)-dione (25). 
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Following the general procedure for reduction of carboxylic acids, using the mixture of 
diastereoisomers 55 (0.027 g, 0.078 mmol, 1 eq) and DMS solution (0.085 mL, 0.17 mmol, 
2.2 eq) in dry THF (0.5 mL), the mixture of diastereoisomeric alcohols (ratio 10:1 obtained by 
integration of the proton at 3.31 ppm and 3.91 ppm) 25 (0.020 g, 0.059 mmol, 76% yield) 
was obtained as colorless oil. 
 
RF (AcOEt) = 0.53. 
 
MP 192.3-193.8°C (decomp.). 
 
1H NMR (400 MHz, Chloroform-d) δ 8.40 (s, 1H, thymine-NH, minor and major 
diastereoisomers), 7.58 (d, J = 1.3 Hz, 1H, thymine vinyl-CH, minor diastereoisomer), 7.46 
(dd, J = 8.9, 5.2 Hz, 2H, Ar-H, major diastereoisomer), 7.33 (dd, J = 8.9, 5.2 Hz, 2H, Ar-H, 
minor diastereoisomer), 7.01 (t, J = 8.7 Hz, 4H, Ar-H, minor and major diastereoisomers), 
6.82 (d, J = 1.3 Hz, 1H, thymine vinyl-CH, major diastereoisomer), 6.23 (d, J = 7.0 Hz, 1H 
tetrahydrofuran-NCH, minor diastereoisomer), 6.19 (dd, J = 6.9, 3.4 Hz, 1H tetrahydrofuran-
NCH, major diastereoisomer), 3.91 (dd, J = 10.6, 6.0 Hz, 1H, -CH2OH, major 
diastereoisomer), 3.75 (dd, J = 10.6, 7.5 Hz, 1H, -CH2OH, major diastereoisomer), 3.31 (dd, 
J = 11.2, 5.1 Hz, 0H, -CH2OH, minor diastereoisomer), 3.23 (dd, J = 11.2, 6.0 Hz, 0H, -
CH2OH, minor diastereoisomer), 2.72 (m, 2H, tetrahydrofuran-CH, minor and major 
diastereoisomers), 2.45 – 2.22 (m, 4H, tetrahydrofuran-CH2, minor and major 
diastereoisomers), 1.89 (d, J = 1.2 Hz, 3H, thymine methyl, minor diastereoisomer), 1.81 
(br.s, 1H, OH, minor and major diastereoisomer), 1.66 (d, J = 1.2 Hz, 3H, thymine methyl, 
major diastereoisomer), 1.57 (s, 3H, tetrahydrofuran methyl, minor diastereoisomer), 1.41 (s, 
3H, tetrahydrofuran methyl, major diastereoisomer). 
 
13C NMR (101 MHz, Chloroform-d, Major diastereoisomer) δ 163.5, 162.1 (d, J = 247.3 Hz), 
150.3, 141.5 (d, J = 3.6 Hz), 136.0, 127.0 (d, J = 8.0 Hz), 115.3 (d, J = 21.3 Hz), 110.5, 87.3, 
84.9, 62.5, 47.8, 36.5, 24.3, 12.6. 
 
IR 2981 (w), 2925 (w), 2860 (w), 1680 (m), 1511 (w), 1473 (w), 1273 (w), 1230 (w), 1055 
(m), 1013 (m), 909 (s), 733 (s). 
 
HRMS (ESI) calcd for C17H19FN2NaO4+ [M+Na]+ 357.1221; found 357.1231. 
 
 4.3 Carbonucleoside alcohol. 
Dibenzyl 4-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-phenyl-2-
((triisopropylsilyl)oxy)cyclopentane-1,1-dicarboxylate. (26) 
 
Following the conditions B, using TIPS protected acetophenone 47 (0.17 g, 0.60 mmol, 1.5 
eq) and the corresponding cyclopropane 37 (0.21 g, 0.40 mmol, 1 eq), the pure product 26 
(0.27 g, 0.38 mmol, 94% yield) was obtained as a white crystalline solid. 
 
RF (pent/AcOEt (1:1)) = 0.70. 
 
MP 69.4-73.1°C. 
 
37 
 
1H NMR (400 MHz, Chloroform-d) δ 8.35 (s, 1H, thymine N-H), 7.84 (d, J = 1.6 Hz, 1H, 
thymine vinyl-CH), 7.77 (dd, J = 7.3, 1.8 Hz, 2H, Ar-H), 7.31 – 7.11 (m, 11H, Ar-H), 6.91 – 
6.84 (m, 2H, Ar-H), 5.72 (tt, J = 11.5, 6.9 Hz, 1H, cyclopentane-NCH), 5.19 – 5.03 (m, 2H, 
benzylic-CH2), 4.76 (d, J = 12.3 Hz, 1H, benzylic-CH2), 4.56 (d, J = 12.2 Hz, 1H, benzylic-
CH2), 3.35 (dd, J = 15.1, 11.1 Hz, 1H, cyclopentane-CH2), 3.21 (t, J = 12.4 Hz, 1H, 
cyclopentane-CH2), 2.53 (dd, J = 12.9, 6.9 Hz, 1H, cyclopentane-CH2), 2.38 (dd, J = 15.2, 7.0 
Hz, 1H, cyclopentane-CH2), 1.94 (d, J = 1.2 Hz, 3H, thymine methyl), 1.03 – 0.92 (m, 21H, 
TIPS). 
 
13C NMR (101 MHz, Chloroform-d) δ 171.9, 167.4, 163.4, 151.1, 139.7, 137.3, 135.1, 134.4, 
128.6, 128.5, 128.4, 128.4, 128.4, 128.3, 128.0, 127.4, 111.5, 88.3, 70.4, 67.7, 67.5, 51.2, 
43.6, 38.3, 18.3, 13.9, 12.8. 
One carbone not resolved. 
 
IR 3434 (w), 3160 (w), 3035 (w), 2872 (w), 1682 (s), 1456 (w), 1374 (w), 1136 (w), 1025 (m). 
 
HRMS (ESI) calcd for C41H50N2NaO7S + [M+Na]+ 733.3279; found 733.3271. 
 
The crystal structure has been deposited at the Cambridge Crystallographic Data Centre and 
allocated the deposition number: CCDC 995131. 
 
 
5-Methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl-2-phenylcyclopent-1-ene-1-carboxylic 
acid (27). 
 
Compound 136 (0.10 g, 0.14 mmol, 1.0 eq) and Pd-C (0.030 g, 0.014 mmol, 0.1 eq) were 
stirred in a flame-dried flask under H2 at 57 °C with ethanol (10 mL) 5 min to solubilize the 
starting material, then the reaction was let for 10 min to cool down. The reaction mixture was 
filtered on a pore 5 filter with hot ethanol (50 mL) to afford after solvent evaporation, the pure 
diacid 56 as colorless needles. Then the crude product was heated neat at 80 °C for 16 h. 
After column chromatography using DCM to a mixture of DCM/MeOH (9:1) with 1% AcOH as 
solvent, the pure product 27 (28 mg, 0.090 mmol, 64% yield) was obtained as a colorless oil. 
The corresponding TIPS protected carboxylic acid 57 (14 mg, 0.030 mmol, 20% yield) was 
also isolated as a colorless oil. 
 
RF 57 (DCM/MeOH (9:1)) = 0.37. 
 
RF 27 (DCM/MeOH (9:1)) = 0.21. 
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MP 114.1-115.6 °C. 
 
1H NMR (400 MHz, Chloroform-d) δ 9.20 (d, J = 9.1 Hz, 1H, thymine-NH), 7.37 (s, 5H, Ar-H), 
7.08 (d, J = 1.6 Hz, 1H, , thymine vinyl-CH), 5.37 (tt, J = 8.8, 4.3 Hz, 1H, cyclopentane-NCH), 
3.60 – 3.25 (m, 2H, cyclopentane-CH2), 2.96 (dddd, J = 18.9, 8.2, 3.7, 1.9 Hz, 2H, 
cyclopentane-CH2), 1.92 (d, J = 1.2 Hz, 3H, thymine methyl). 
 
13C NMR (101 MHz, Chloroform-d) δ 168.2, 163.7, 153.1, 150.5, 136.2, 134.4, 128.8, 128.0, 
127.7, 125.7, 111.8, 46.2, 40.8, 12.5. 
 
IR 3169 (w), 3026 (w), 2929 (w), 1675 (s), 1472 (w), 1393 (w), 1270 (m), 1221 (w), 909 (m), 
735 (s), 636 (w). 
 
HRMS (ESI) calcd for C17H15[2H]2N2O4+ [M+H]+ 315.1306; found 315.1300. 
 
 
5-Methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl-2-phenylcyclopentane-1-carboxylic 
acid (60). 
 
Carboxylic acid 27 (0.021 g, 0.067 mmol, 1.0 eq) and Pd-C (0.01 g, 0.007 mmol, 5 % wt, 0.1 
eq) were stirred in a flame dried flask under H2 at room temperature with ethanol (1 mL). TLC 
shows that the reaction was accomplished after 10 minutes and filtered on pore 5 filter. The 
residue was washed several times with hot ethanol. The pure product 58 (0.018 g, 0.057 
mmol, 85% yield) precipitated directly as white spheres. The stereochemistry was assigned 
by NOE experiment. 
 
RF (DCM/MeOH (8:2) 1% AcOH) = 0.49. 
 
MP 227.8-236.9°C. 
 
1H NMR (400 MHz, DMSO-d6) δ 11.86 (s, 1H, -COOH), 11.20 (s, 1H, -NH), 7.80 (d, J = 1.4 
Hz, 1H, , thymine vinyl-CH), 7.29 – 7.10 (m, 5H, Ar-H), 4.97 (dtd, J = 11.3, 9.1, 6.8 Hz, 1H, 
cyclopentane-NCH), 3.48 (ddd, J = 12.3, 9.1, 6.2 Hz, 1H, cyclopentane-CH), 3.19 – 3.00 (m, 
1H), 2.36 – 2.21 (m, 2H, cyclopentane-H), 2.11 (dt, J = 12.3, 6.5 Hz, 1H, cyclopentane-H), 
1.96 (ddd, J = 14.0, 9.0, 5.5 Hz, 1H, cyclopentane-H), 1.76 (d, J = 1.1 Hz, 3H, thymine 
methyl). 
 
13C NMR (101 MHz, DMSO-d6) δ 176.3, 164.2, 151.6, 140.8, 137.9, 128.5, 128.4, 126.9, 
109.9, 53.6, 47.2, 45.3, 35.6, 33.9, 12.8. 
The carboxylic acid carbon is not resolved. 
 
IR 3225 (w), 2959 (w), 2860 (w), 1686 (s), 1636 (s), 1449 (m), 1380 (m), 1280 (s), 1213 (m), 
1054 (s), 950 (s), 784 (s). 
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HRMS (ESI) calcd for C17H19N2O4+ [M+H]+ 315.1339; found 315.1344. 
 
5-Methyl-1-(3-phenyl-4-(((triisopropylsilyl)oxy)methyl)cyclopentyl)pyrimidine-
2,4(1H,3H)-dione (28). 
 
Carboxylic acid 58 (0.019 g, 0.060 mmol, 1 eq) was solubilized in dry THF (0.35 mL) in a 
dried round bottom flask. The reaction mixture was cooled under nitrogen to 0°C and a 2 M 
dimethylsulfide borane solution in THF (0.076 mL, 0.15 mmol, 2.2 eq) was added dropwise. 
The reaction was stirred at 0 °C for 5 hours, then it was quenched by addition of a 1 M HCl 
solution (1 mL). The mixture was extracted three times with AcOEt (3 mL) and the organic 
layers were dried over anhydrous MgSO4. The crude was directly solubilized into dry and 
degassed DMF (0.7 mL), imidazole (6 mg, 0.09 mmol, 1.5 eq) and TIPSCl (14 mg, 0.072 
mmol, 1.2 eq) were added. The mixture was stirred at room temperature for 6 hours. The 
solvent was removed under reduced pressure and the mixture was partitioned between 
water (2 mL) and AcOEt (2 mL). The aqueous layer was extracted 3 times with AcOEt and 
the organic layers were dried over anhydrous Na2CO3 and concentrated under reduced 
pressure. The crude yellow oil was purified by column chromatography, starting with pure 
DCM and then changing gradually to a mixture of DCM/MeOH (9:1), affording the pure 
protected alcohol 28 (15 mg, 0.033 mmol, 55%) as a colorless oil. 
 
RF (DCM/MeOH (9:1)) = 0.58. 
 
1H NMR (400 MHz, Chloroform-d) δ 8.54 (s, 1H, -NH), 7.32 – 7.09 (m, 6H, Ar-H and thymine 
vinyl-CH), 5.05 (dtd, J = 11.6, 9.4, 6.5 Hz, 1H, cyclopentane-NCH), 3.42 – 3.21 (m, 3H, CH2O 
and cyclopentane-CH), 2.46 (td, J = 9.0, 4.7 Hz, 1H, cyclopentane-CH), 2.39 – 2.27 (m, 1H 
cyclopentane-CH), 2.27 – 2.13 (m, 2H, cyclopentane-CH), 1.96 – 1.91 (m, 1H, cyclopentane-
CH), 1.89 (d, J = 1.2 Hz, 3H, thymine methyl), 0.93 (m, 3H, TIPS), 0.88 (d, J = 4.9 Hz, 18H, 
TIPS). 
 
13C NMR (101 MHz, Chloroform-d) δ 163.5, 151.2, 139.9, 136.6, 128.3, 128.0, 126.4, 111.0, 
64.0, 54.6, 44.8, 42.1, 35.3, 32.1, 18.0, 18.0, 12.4, 11.8. 
 
IR 3170 (w), 2945 (w), 1687 (s), 1469 (m), 1385 (w), 1272 (w), 1126 (w), 884 (w). 
 
HRMS (ESI) calcd for C26H41N2O3Si+ [M+H]+ 457.2881; found 457.2881. 
 
 
 
 
5. Spectra of new compounds 
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NOESY 1D experiment permitted to define the stereochemistry of the new stereocenter. In 
fact, we were able to see the NOE interaction between the thymine NCH proton (H1) and the 
cyclopentane methyl (Me) and the cyclopentane CH (H2). The absence of coupling between 
thymine NCH proton (H1) and the cyclopentane CH (3.37 ppm) one is also supporting this 
assignment.  
Me H2
  H1 
H1 
H1 irradiation 
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400 MHz, MeOH-d. 
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400 MHz, Acetone-d. 
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NOESY 1D experiment permitted to define the stereochemistry of the new stereocenter. In 
fact, we were able to see the NOE interaction between the cyclopentane proton (H1) and the 
thymine NCH proton (H3) and the proton (H2). 
  
H1 
H2 
H3 
H1 irradiation 
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400 MHz, MeOH-d. 
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NOESY 1D experiment permitted to define the stereochemistry of the new stereocenter. In 
fact, we were able to highlight see the NOE interaction between the cyclopentane proton (H3) 
and the three other protons H2, H1 and H4. 
H1 
H2 H3 
H4 
H1 irradiation 
